Clemson University

TigerPrints
All Dissertations

Dissertations

8-2018

Physiological and Environmental Impacts of
Nanomaterials-Biomolecular Coronae
Achyut J. Raghavendra
Clemson University, araghav@g.clemson.edu

Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations
Recommended Citation
Raghavendra, Achyut J., "Physiological and Environmental Impacts of Nanomaterials-Biomolecular Coronae" (2018). All Dissertations.
2196.
https://tigerprints.clemson.edu/all_dissertations/2196

This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by
an authorized administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.

PHYSIOLOGICAL AND ENVIRONMENTAL IMPACTS OF NANOMATERIALS—
BIOMOECULAR CORONAE

A Dissertation
Presented to
the Graduate School of
Clemson University

In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
Physics

by
Achyut J. Raghavendra
August 2018

Accepted by:
Dr. Ramakrishna Podila, Committee Chair
Dr. Apparao M. Rao
Dr. Feng Ding
Dr. Jeremy Tzeng

ABSTRACT

Engineered nanomaterials (ENMs) exhibit unique electronic and optical properties, which
are suitable for the broad spectrum of applications including biomedical, aerospace,
textiles, agriculture. Such unique properties of ENMs also raise significant concerns over
their adverse ecological and physiological effects. In the past two decades, ENMs were
found to exhibit complex interactions in biological milieu. It is expected that
physicochemical properties of ENMs and their surrounding environment influence their
environmental and physiological fate and transport. Indeed, a comprehensive
understanding of interactions at the nano-bio interface is critical to designing
environmentally and physiologically benign ENMs pivotal to the future growth of
nanomedicine and its applications. To this end, the present work experimentally
investigates nanomaterial-biomolecular corona (or biocorona) using spectroscopic
techniques and biological assays. Specifically, the influence of defects, surface
functionalization, and physiological environment on the formation of biocorona and
ensuing biological responses is presented.
The first two chapters (Chapters 1 and 2) provide a succinct introduction to
nanotoxicity

with

focus

on

biocorona

formation

and

various

spectroscopic

characterization techniques utilized. In Chapter 3, the variation in biocorona formation
due to defects in the structure of single-walled and multi-walled carbon nanotubes
(SWCNTs and MWCNTs) is presented. Briefly, it was found that defects result in
significant changes in the nature and amount of proteins adsorbed on SWCNTs due to
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differences in their charge distribution. In case of MWCNTs, carboxylated MWCNTs
with higher density of defects resulted in a stronger binding and efficient delivery of
antigens. In Chapter 4, a unique study exploring the effect of diseased (hyperlipidemic)
physiological state on the biocorona composition (instead of the normal healthy state) is
presented. Our findings suggest that disease-induced variations in the physiological
environment have a significant impact on nanomaterial-biomolecular corona, cell
response, and cellular association.
In Chapter 5 provides new spectroscopic insights into charge transfer interactions
between biomolecules (aromatic amino acid complexes) and emerging two-dimensional
(2D) ENMs like graphene, graphene oxide, and BN. The adsorption of amino acids on
2D materials was observed to considerably alter their biological response in terms of
generation of reactive oxygen species. Also, the influence of different surface functional
groups on Ag nanoparticles on conformational changes in apolipoprotein biocorona and
ensuing biological is explored. Finally, Chapter 6 explores environmental effects of
graphene, BN upon their interaction with natural organic matter (NOM). The results
show that the delocalized -electron cloud in graphene facilitated a significant charge
transfer and chemisorption of NOM unlike BN. Also, BN was found to result in algal cell
rupture and reduction in photosynthetic activity unlike graphene.

iii

DEDICATION

To my beloved family, for their continual support to my endeavors.

iv

ACKNOWLEDGMENTS

I would like to express my deepest appreciation to my research advisers Dr.
Ramakrishna Podila and Dr. Apparao M. Rao for their continuous guidance and scientific
insights which benefited me. They helped me make a drastic career transition from
engineering to emerging interdisciplinary nano-biophysics field. Their passion for
science, work ethics, and immense knowledge has truly been the inspiration for all who
work around them. Dr. Ramakrishna Podila’s contribution towards this dissertation as
well as to my career growth is immense. His unique subject perspective has enhanced my
understanding and appreciation of nano-biophysics.
My work wouldn’t have been possible without our prime collaborator Dr. Jared
M. Brown, University of Colorado Anschutz Medical Campus, who provided extensive
guidance and encouragement. Many thanks to his team members Monica Johnson,
Kristofer Fritz, and Indushekhar Persaud for help conducting cell studies and shaping this
dissertation. I thank Dr. Brian A. Powell for training me on mass spectrometry
measurements, which I have used notably in my studies. I wish to thank all my Ph.D.
committee members – Dr. Feng Ding, and Dr. Jeremy Tzeng for their expertise and
suggestions during my research.
I express my gratitude to Dr. Anurag Srivastava (ABV-Indian Institute of
Information Technology and Management), Dr. Pradyumna Mulpur, and Dr. Jonathan
Shannahan (Purdue) for their collaborations. I would like to thank Dr. Terry Bruce and
Tyler Slonecki at Clemson for helping me with cell culture studies.

v

This dissertation would not have been possible without my beloved colleagues:
Herbert Behlow for his ingenious problem-solving skills, machine shop team who
delivered perfection to all requirements, and Dr. Sriparna Bhattacharya for her guidance
through projects and presentations. Many thanks to my lab mates Wren Gregory, Sai
Sunil Mallineni, Bishwambhar Sengupta, Anthony Childress, Fengjiao Liu, Longyu Hu,
Lakshman, and Yongchang Dong.
Thanks to Ethan Kilgore and Anthony Childress for bearing me in our amazing
hiking adventures around Clemson area. Last but not least thanks to my roommates
Nakul, Rishwanth, Areeb, Vijay, and Abha, for tolerating me all along. And all friends
who made each day at Clemson memorable.

vi

TABLE OF CONTENTS

Page
TITLE PAGE .................................................................................................................... i
ABSTRACT ..................................................................................................................... ii
DEDICATION ................................................................................................................iii
ACKNOWLEDGMENTS .............................................................................................. iv
LIST OF TABLES ........................................................................................................viii
LIST OF FIGURES ........................................................................................................ ix
CHAPTER
1.

NANOTOXICITY REVIEW......................................................................... 1
1.1 Nanomaterial-biomolecular corona ................................................... 2
1.2 Relation to physicochemical properties of nanomaterials ................. 5

2.

SPECTROSCOPIC CHARACTERIZATION TECHNIQUES .................. 10
2.1 Hyperspectral imaging ..................................................................... 11
2.2 Circular dichroism spectroscopy...................................................... 13
2.3 Infrared spectroscopy ....................................................................... 15
2.4 Electrochemical impedance spectroscopy ....................................... 18

3.

EFFECT OF DEFECTS IN CARBON NANOTUBES ON CORONAL
COMPOSITION AND ITS FATE......................................................... 22
3.1 Introduction ...................................................................................... 22
3.2 Materials and methods ..................................................................... 27
3.2.1 Preparation and characterization of MWCNT-ovalbumin
complex ................................................................................. 27
3.2.2 Synthesis and characterization of SWCNTs ......................... 28
3.2.3 Animals and cell models ....................................................... 28
3.3 Results and discussion ..................................................................... 32
3.3.1 Case of MWCNTs................................................................. 32
3.3.2 Case of SWCNTs .................................................................. 41
3.4 Conclusions ...................................................................................... 54

vii

Table of Contents (Continued)
Page
4.

DISEASE INDUCED DISPARITIES IN CORONAL FORMATION ....... 55
4.1 Introduction ...................................................................................... 55
4.2 Materials and methods ..................................................................... 58
4.2.1 Isolation of normal and hyperlipidemic rat serum ................ 58
4.2.2 Formation and characterization of Fe3O4 nanoparticlebiocorona............................................................................... 59
4.2.3 Cellular uptake and cytotoxicity ........................................... 61
4.2.4 Formation and evaluation of SWCNT-biocorona ................. 65
4.3 Results and discussion ..................................................................... 68
4.3.1 Case of Fe3O4 ........................................................................ 68
4.3.2 Case of SWCNTs .................................................................. 75
4.4 Conclusions ...................................................................................... 80

5.

CHARGE TRANSFER INTERACTIONS OF NANOMATERIALS WITH
BIOMOLECULES ................................................................................ 82
5.1 Introduction ...................................................................................... 82
5.2 Materials and methods ..................................................................... 86
5.3 Results and discussion ..................................................................... 89
5.3.1 Two-dimensional nanomaterials with aromatic amino acids 89
5.3.2 Effect of surface functional groups on AgNP-apolipoprotein
biocorona............................................................................. 101
5.4 Conclusions .................................................................................... 112

6.

ENVIRONMENTAL IMPACTS OF TWO-DIMENSIONAL
NANOMATERIALS .......................................................................... 114
6.1 Introduction .................................................................................... 114
6.2 Materials and methods ................................................................... 115
6.3 Results and discussion ................................................................... 117
6.4 Conclusions .................................................................................... 128

7.

SUMMARY AND FUTURE WORK ....................................................... 129

APPENDIX…. ............................................................................................................. 130
REFERENCES ............................................................................................................ 131

viii

LIST OF TABLES

Table

Page

1.2.1

Effect of various nanoparticle properties on biocorona Reproduced with
permission from Nguyen et al. [1]. ................................................................ 6

3.3.1

Alterations in surface area of SWCNTs due to ball milling measured by BET
analysis. ........................................................................................................ 45

4.3.1

Fe3O4 NP-Biocorona Characterization (n=3). * denotes statistical difference
from Fe3O4 without BC (p ≤ 0.05). # denotes statistical difference from Fe3O4
– Normal BC (p ≤ 0.05) ............................................................................... 68

5.3.1

The positions of Raman peaks for graphene, graphene oxide, and BN-amino
acid complexes derived from Fig 5.2.5 ........................................................ 99

5.3.2

Positions of deconvoluted 2D-band for graphene derived from Fig.5.2.2... 99

6.3.1

Zeta potential values to understand the stability of NOM with 2D
materials. .................................................................................................... 119

6.3.2

Freundlich adsorption model parameters for graphene, BN with NOMs. . 121

ix

LIST OF FIGURES

Figure

Page

1.1.1

PubMed entries to search criteria ‘nanoparticle AND corona’ since 2000 ... 2

1.1.2

Depending on protein affinity to nanoparticle surface two distinguishable
layers (hard and soft) are formed as shown in this schematic. The complexity
of biocorona composition (both hard and soft corona) due to the availability of
various proteins is illustrated with different colors and shapes here. Modified
with permission from ref [2] .......................................................................... 4

1.2.1

Important factors affecting formation of biocorona classified under
nanoparticle properties and its surrounding environment. ............................. 6

2.1.1

(a) Hyperspectral enhanced darkfield images of macrophages exposed to
AgNPs and AgNPs with protein corona for 2 h, at a concentration of
25μg/mL. Macrophage nucleus appears blue in the images due to DAPI stain.
(b) Differences in mean spectra for AgNPs with different sizes (20 and 110
nm) and coatings (PVP and citrate). Based on such shifts in plasmon energies,
it is possible to study the uptake and modification of AgNPs using
hyperspectral imaging. ................................................................................. 13

2.2.1

(a) Circular dichroism (CD) spectra for ApoA-I incubated with AgNPs of
different surface coatings (citrate, PVP, bPEI, and lipoic acid) shows (b)
marked decrease in α-helix content with corresponding increase in β-sheets
and irregular structures. Spectra were analyzed using CAPITO (a CD Analysis
& Plotting Tool) and secondary structure content was estimated. CD
spectroscopy provides secondary and tertiary protein structure content
estimation of biomolecules, which is critical for analyzing conformational
changes during ENM-protein interactions. .................................................. 15

2.3.1

(a-c) Snapshots of MD simulations showing BSA on SWNT, GNR, and
GONR 10 ns after adsorption. (d-f) show the top-view. The adsorption is
accompanied by disruption of a-helices into random peptide chains (shown in
orange). ........................................................................................................ 17

2.4.1

(a) FTIR spectra for native BSA, BSA-adsorbed on MWNTs, GNRs, and
GONRs show that the CNMs significantly affected the secondary structures of
the proteins. The absorption peak for α-helix in native BSA, in the range from
1640 to 1660 cm-1 (indicated by the vertical dashed lines), showed a
significant reduction (disappeared for MWNTs) for all CNMs suggesting that
the secondary structure of BSA adsorbed on CNMs was less compact.

x

List of Figures (Continued)
Figure

Page
(b) In the case of fibrinogen, the loss of secondary structure was highest for
GONRs possibly due to the formation of hydrogen bonds. While both
MWNTs and GNRs exhibited a loss of α-helical content, the appearance of
new peak ~1500 cm-1 (corresponding to random motifs) in GNRs suggested a
lesser degree of relaxation for fibrinogen, compared to MWNTs ............... 20

3.3.1

TEM analysis of carboxylated MWCNT-2 (A) and MWCNT-30 (B). The
outer diameters of carboxylated MWCNT-2 and MWCNT-30 were 26 ± 5 nm
and 18 ± 3 nm, respectively. The average length of both carboxylated
MWCNTs was ~500 nm. ............................................................................. 32

3.3.2

The Raman spectra of carboxylated MWCNT-2 and MWCNT-30. The Dband (~1350 cm-1) was found along with the characteristic G-band (~1580
cm-1). Both MWCNTs also exhibited at a higher frequency shoulder to the Gband (known as the D’ band ~1620 cm-1) suggesting high defect densities in
MWCNTs. The ratio of D- to- G band areas (ID/IG) was 0.97 and 1.37 for
MWCNT-2 and MWCNT-30, respectively, indicating that MWCNT-30
samples contain more defects. ..................................................................... 34

3.3.3

Effects of ovalbumin coating on the hydrodynamic size and zeta potential of
MWCNTs. (A) Ovalbumin coating increased the hydrodynamic size of
MWCNTs (A) but had little impact on the zeta potential of MWCNTs (B).
(n=3, mean ± SD, * p>0.05 comparison between MWCNTs with and without
ovalbumin coating) ...................................................................................... 35

3.3.4

Binding of OVA to MWCNTs confirmed by photoluminescence
spectroscopy. ................................................................................................ 36

3.3.5

Delivery of fluorescent Texas Red-conjugated ovalbumin by MWNCT-2 into
bone marrow derived macrophages (BMDM) visualized by darkfield and
fluorescent microscopy. Macrophages with or without treatment with
MWCNTs alone showed no fluorescence, but macrophages treated with
ovalbumin and MWCNT-TR-OVA complex displayed strong fluorescence.
(Magnification: 100 X) ................................................................................ 38

3.3.6

Effects of MWCNTs or MWCNT-OVA complex on cellular viability of
BMDM using MTS assay (n=6, mean ± SD). MWCNTs or MWCNT-OVA
complex showed no observable effect on the cellular viability of macrophages
up to 5 days. ................................................................................................. 39

xi

List of Figures (Continued)
Figure

Page

3.3.7

MWCNT-OVA complex remarkably induced CD4+ T cell proliferation. (A)
Proliferation of OT-II CD4+ T cells after co-culture with untreated
macrophages (black line) and ovalbumin-treated macrophages (red line), (B)
proliferation of OT-II CD4+ T cells after co-culture with macrophages treated
with MWCNT-2 (black line) and MWCNT-2-OVA complex (red line), and
(C) proliferation of OT-II CD4+ T cells after co-culture with macrophages
treated with MWCNT-30 (black line) and MWCNT-30-OVA complex
(red line). ...................................................................................................... 41

3.3.8

A. Radial breathing modes from the Raman spectra of As Prepared SWCNTs
suggest a diameter distribution ~1.4 nm. The spectra were collected using
both 514 and 1064 nm to probe all SWCNT populations. B. Alterations in the
defect band (D-band ~1350 cm-1) in ball milled SWCNTs evidenced by their
Raman spectra. All the spectra were normalized to the graphitic or G-band to
obtain the ID/IG ratio that is indicative of the defect density. Also, the plot of
ID/IG vs. duration of ball milling (inset) shows that there is an initial rapid
increase for 2 h ball milling followed by a saturation in the defects with
increasing ball milling time. The spectra shown in A and B are averaged over
at least three different sets. C. The photoluminescence spectra of As Prepared
and ball milled SWCNTs showed an emission peak ~1560 nm. The presence
of strong emission, unique to the tubular structure of SWCNTs, confirms that
the defects were introduced while still retaining the tubular morphology. All
characterization experiments were performed with an n ≥ 3. ...................... 44

3.3.9

Venn diagrams representing the number of proteins found to associate with
SWCNTs following incubation in 10% normal serum comparing As Prepared
SWCNTs to SWCNTs that have undergone ball milling. ........................... 47

3.3.10

Relative abundance of proteins found to associate with 2h ball milled
SWCNTs compared to As Prepared SWCNTs in normal serum. ................ 49

3.3.11

Differences in relative abundance of specific proteins (Transthyretin,
Clusterin, Complement C1q Subcomponent Subunit B, and Alpha-2-HSGlycoprotein) found to associate with SWCNTs in either normal serum due to
ball milling time. All ratios are As Prepared SWCNTs : Ball-Milled
SWCNTs. ..................................................................................................... 50

4.3.1

Venn diagram representing the distribution of protein components found to
associate with 20 nm Fe3O4 NPs following incubation in 10% normal (blue) or
hyperlipidemic (red) serum. ......................................................................... 68

xii

List of Figures (Continued)
Figure

Page

4.3.2

False-colored transmission electron micrographs for (a) Fe3O4 NPs, (b) Fe3O4Normal BC, and (c) Fe3O4-Lipid BC. Biocorona is shown in blue (b) and
green colors (c). The Fe3O4 NPs were observed to be embedded in BC. The
black arrows in (c) show liposome structures formed in Fe3O4-Lipid
BC. ............................................................................................................... 69

4.3.3

Measurement of 20 nm Fe3O4 NP uptake by ICP-MS and darkfield
microscopy. Rat aortic endothelial cells (RAEC) were exposed to serum-free
media (control), Fe3O4 NPs without a biocorona (BC), or Fe3O4 NPs with
either a normal serum or lipid serum BC. Cells were exposed to a
concentration of 20 μg/ml for 2 h under flow conditions of 1 ml/min. A)
Following exposure, cells were assessed by ICP-MS for Fe3O4 NP uptake.
Values are expressed as mean ± SEM (n=3/group). * Indicates significant
difference from controls (p < 0.05). B) Alterations in RAEC uptake of Fe3O4
NPs due to the addition of BCs was qualitatively evaluated via darkfield
microscopy. Fe3O4 NPs without a BC are identified with red arrows, Fe3O4
NP-normal BC with blue arrows, and Fe3O4 NP-lipid BC with green
arrows. .......................................................................................................... 70

4.3.4

Assessment of Fe3O4 NP-BC alterations in cell surface expression of VCAM1 by immunofluorescent staining. Rat aortic endothelial cells (RAEC) were
exposed to serum-free media (control), Fe3O4 NPs without a BC or Fe3O4 NPs
with either a normal serum or lipid serum BC. Cells were exposed to a
concentration of 20 μg/ml for 1 h under flow conditions of 1 ml/min. Cells
were then immunofluorescently stained with DAPI to identify the nucleus
(Blue) and with a VCAM-1 antibody to identify endothelial cell surface
expression of VCAM-1 (Green). ................................................................. 74

4.3.5

Venn diagrams representing the number of proteins found to associate with
SWCNTs due to incubation in either normal or hyperlipidemic serum. ..... 76

4.3.6

Differences in relative abundance of specific proteins (Transthyretin,
Clusterin, Complement C1q Subcomponent Subunit B, and Alpha-2-HSGlycoprotein) found to associate with SWCNTs in hyperlipidemic serum due
to ball milling time. For normal serum refer Fig. 3.3.11. All ratios are As
Prepared SWCNTs : Ball-Milled SWCNTs. ............................................... 77

5.3.1

Representative transmission electron microscope images for (a) graphene, (b)
graphene oxide, and (c) BN. (d) Raman spectra for as-prepared graphene

xiii

List of Figures (Continued)
Figure

Page
(red), graphene oxide (green) and boron nitride (blue). The D-band (~1350
cm-1) and the G-band (~1590 cm-1) for graphene oxide exhibit significant
broadening due to the presence of defects. Graphene (G-band ~1585 cm-1) and
BN (~1366 cm-1) exhibit sharp Raman features indicative of good
crystallinity. ................................................................................................. 90

5.3.2

Adsorption isotherms for (a) tyrosine, (b) tryptophan, and (c) phenylalanine
on graphene, BN, and graphene oxide. Graphene oxide showed significantly
higher adsorption of tyrosine and tryptophan, possibly due to the formation of
hydrogen bonds, compared to graphene and BN (which exhibit
interactions with amino acids). However, phenylalanine showed similar
adsorption on all 2D materials that was relatively independent of
concentration. ............................................................................................... 91

5.3.3

(a) A graphene sheet containing p-electrons can be viewed as a quadrupole (as
depicted by green lobes in the lower panel) with a negative charge above and
below the sheet and a positive charge around the edges. Similarly, the
aromatic ring (shown in red) in tyrosine, tryptophan, and phenylalanine could
be viewed as quadrupoles with charge distribution similar to graphene. Amino
acids (e.g., tyrosine shown above graphene sheet) exhibit either edge-to-face
or off-centered (b) stacking due to quadrupole-mediated p-p interactions. (c)
BN exhibits positive charge (shown in purple) above and below the sheet due
to the presence of N atoms that pull the electrons away from the center.
Accordingly, the amino acids may prefer face-centered stacking, unlike
graphene. ...................................................................................................... 92

5.3.4

(a) Cyclic voltammetry loops for graphene and tryptophan show the
appearance of a new peak ~0.6-0.8 V indicating irreversible charge transfer.
(b-d) Charge density isotherms derived from their corresponding CV loops for
different 2D materials and amino acid combinations. Insets shows zoomed in
view of the plot of charge density vs concentration for Gr and BN. ........... 95

5.3.5

(a) Raman spectra of graphene oxide-amino acid complexes showed
significant shifts due to the formation of hydrogen bonds with amino acids.
The starred peaks arise from tyrosine due to its high Raman cross-section. (b)
Raman spectra for graphene-amino acids complexes show shifts in G- and
2D-bands (in (b) and (c) respectively) indicating the involvement of charge
transfer between amino acids and graphene. Solid lines in indicate fits to the
experimental data. The red curves in panel (c) are deconvoluted peaks for 2Dband in graphene. ......................................................................................... 98

xiv

List of Figures (Continued)
Figure

Page

5.3.6

Transmission electron micrographs showing as-purchased Ag NPs (a-d) with
citrate, PVP, bPEI and lipoic acid coatings respectively. The presence of
biocorona (see arrows in e-h) upon incubation with ApoA-I was assessed
using OsO4 staining as shown in (e-h). Scale bar is 100 nm. .................... 101

5.3.7

(a) The hydrodynamic size of AgNPs was found to change with increasing
ApoA-I concentrations with saturation >2 g/L for AgNP-PVP, citrate, and
lipoic acid coatings. AgNP-bPEI, however, did not show such saturation. (b)
The zeta potential measurements showed clear changes indicating the
displacement of surface coatings by ApoA-I. All surface coatings showed
saturation in zeta potential changes >2 g/L excepting AgNP-lipoic acid. Based
on (a) and (b), it could be inferred that AgNP-bPEI and AgNP-lipoic acid do
not show saturation in protein adsorption even at high ApoA-I concentrations.
It should be noted that the physiological concentration of ApoA-I is 1.3-1.5
g/L. ............................................................................................................. 103

5.3.8

(a) Cyclic voltammetry scans showed the appearance of a peak (blue arrows)
for AgNP electrodes in ApoA-I electrolyte suggesting the presence of chargetransfer stabilizing interactions. The peak for AgNP-bPEI occurred only in the
forward scan (going from -0.4 to 0.8 V) indicating irreversible charge transfer.
A valley (red arrows), the representative of reversible charge transfer, was
observed for other surface coatings on the reverse scan (0.8 to -0.4 V). (b) The
total charge enclosed by the CV curves in (a) displayed clear increasing trends
with ApoA-I concentration confirming that the charge-transfer occurs due to
interactions between ApoA-I and AgNPs. ................................................. 107

5.3.9

DCF assay was used to evaluate the ability of AgNPs with (+Apo) and
without (-Apo) ApoA-I corona to generate reactive oxygen species (ROS).
AgNP-bPEI-ApoA-I displayed a significant increase in ROS generation
compared to AgNP-bPEI while the response to AgNP-lipoic acid-ApoA-I was
significantly higher than the control. These changes may be attributed the
protein unfolding observed in AgNP-bPEI and AgNP-lipoic acid (cf. Fig.
2.2.1). ......................................................................................................... 110

6.3.1

High-resolution transmission electron microscope images of pristine graphene
and BN show a layered structure with ~10-15 layers for graphene and 20-15
layers for BN. The insets show graphene and BN flakes at lower
magnification with lateral sheet dimensions >1 m .................................. 118

xv

List of Figures (Continued)
Figure

Page

6.3.2

Adsorption isotherms of NOM on (a) graphene and (b) BN showed that
Suwanee River NOM (SRNOM) exhibited higher affinity relative to Nordic
reservoir NOM (NRNOM) and humic acid (HA) that have lower aromatic
content. The solid lines are fits obtained using Freundlich equation. The fitting
parameters are listed in Table 6.3.2. .......................................................... 120

6.3.3

Cyclic voltammograms of graphene and BN in (a) Suwanee River NOM
(SRNOM) and (b) Nordic reservoir NOM (NRNOM): A clear irreversible
charge transfer peak (indicated by solid arrows) was observed for graphene
while BN did not exhibit any peaks. The dashed arrows indicate the
electrolysis of water in the electrolyte at higher voltages. A slow scan rate (~ 5
mV/s) was used in order to exclude any electrolyte diffusion effects ....... 123

6.3.4

Charge transfer isotherms for Suwannee Rive & Nordic reservoir NOM
(SRNOM and NRNOM) on 2D-ENMs show that NOM adsorption on
graphene involves chemisorption, unlike BN. The observed differences
between graphene and BN could be attributed to the delocalized -electron
cloud in graphene that facilitates charge transfer with aromatic content in
NOM. ......................................................................................................... 124

6.3.5

(a-c) Algae incubated in graphene, graphene with Suwannee and graphene
with Nordic. (d-f) Algae incubated in BN, BN with Suwannee and BN with
Nordic. The scale bar is 100 µm. ............................................................... 126

6.3.6

CO2 depletion rate measured at 574 nm (as absorbance peak occurs for
bicarbonate indicator) for (a) graphene and (b) BN samples at different
intervals of time upon incubation with algae. ............................................ 127

xvi

CHAPTER ONE
NANOTOXICITY REVIEW

In the past decade, nanomaterial-based products found their way to consumer
stores translating nanotechnology from bench to bedside. Nanotechnology impacted
several industries including energy, medical, sports, electronics, agriculture, and textiles.
Vance et al.[3] reported a thirty-fold increase in a number of nano engineered products
between 2005 and 2015. Among fast-growing metal nanoparticles applications, silver
takes a major share of 24% in the market. Therefore, human and environmental exposure
to nanomaterials is inevitable. Despite the broad range of nanomaterial applications, its
use is limited owing to its potential risks to the environment and human population.
Nanotoxicity is a field of research dedicated to understanding potential risks
associated with the use of engineered nanomaterials (ENMs) to both humans and
environment. Although concerted research efforts led to an initial assessment of
nanomaterial toxicity in the last decade, there has been a lack of fundamental
understanding of nano-bio interactions in terms biomoelcular adsorption or biocorona. To
impress the relevance of this research interest, a database query on PubMed with
‘nanoparticle AND corona’ in search criteria yielded ~1000 entries as shown in Fig.
1.1.1. The trend shows a three-fold increase in a number of reports since 2012, which
strongly suggests that the nanoparticle corona began to gain attention in the last five
years.

1

Figure 1.1.1: PubMed entries to search criteria ‘nanoparticle AND corona’ since 2000.

This chapter briefly describes the transport and fate of ENMs in our ecosystem
and reviews findings in the literature exploring nanomaterials toxicity and its influential
factors. The inadvertent fouling of ENMs by biomolecules provides a biological identity,
which could potentially trigger undesired physiological responses. The following sections
discuss various physicochemical properties of ENMs, which dictate the formation and
composition of nanomaterial-biomolecular corona or boicorona and in turn their
toxicological effects on physiology and environment.

1.1 Nanomaterial-biomolecular corona (or biocorona)

Global research efforts have led to a better understanding of nanomaterial
toxicity. Yet, the fundamental mechanisms through which nano–bio interactions occur

2

still remain largely inconclusive.[4] Building on the understanding of adsorbed
biomolecules in cellular responses to biomaterials, a new picture of nanotoxicity based on
protein-nanomaterial interactions is recently beginning to emerge.[5]–[7] Upon their
introduction to any physiological environment, the surface of nanomaterials gets coated
with various biomolecules including proteins, peptides, and lipids collectively referred to
as the nanomaterial-biomolecular corona or biocorona. Interestingly, it is the biocorona
that dictates the fate of nanomaterials in any biological medium rather than the bare
nanomaterial itself.
Biocorona is formed due to the high surface free energy of ENMs, leading to
adsorption of many biomolecules, most prominently proteins in order to reduce surface
free energy. Although at the initial stage most abundant proteins present in the
physiological medium adsorb onto the ENM surface, these proteins will be swapped by
proteins with higher affinity over time (Vroman’s effect [8]). The adsorption process is
governed by protein-protein interactions as well as protein affinities for the ENMsurface.
As shown in the schematic Fig 1.1.2 proteins with higher binding affinities form “hard”
biocorona and low binding affinity proteins form the “soft” biocorona. Hard biocorona
proteins is known to interact with ENM surface through van der Walls interactions,
hydrogen bonds, electrostatic interactions, and hydrophobic interactions whereas soft
biocorona proteins interact via weak protein-protein interactions. These hard and soft
layers are also distinguishable depending on the exchange rates. While the soft layer is
thought to be dynamic, the hard layer is stable with exchange times in the order of
hours.[9]
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Figure 1.1.2: Depending on protein affinity for nanoparticle surface two distinguishable
layers (hard and soft) are formed as shown in this schematic. The complexity of
biocorona composition (both hard and soft corona) due to the availability of various
proteins is illustrated with different colors and shapes here. Modified with permission
from ref [2].

The nature (structure and composition) of the biocorona is found to be complex
and unique for all nanomaterials dependent on several parameters such as nature of the
physiological environment, exposure time, and physicochemical properties of ENMs
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(composition, size, shape, surface charges, surface functional groups). It is also known
that adsorbed proteins in biocorona may undergo structural rearrangement or
conformational changes, which could alter protein interaction with other biomolecules.
Nanoparticle composition and its surface chemistry are also found to be key in
identifying binding proteins and their affinities. Hence, a thorough understanding of all
factors is critical for the safe design of nanomaterials.

1.2 Relation to physicochemical properties of nanomaterials and its environment

ENMs exhibit optical, electrical, magnetic, and mechanical properties distinct
from their bulk counterparts. Due to their small size, ENMs can easily cross biological
barriers (e.g., blood-brain barrier) and could cause undesired biological implications.
Broadly speaking, all factors affecting nano-bio interactions could be categorized under
physicochemical properties of ENMs and the exposed environment as shown in Fig.
1.2.1.[1] These parameters have also been reviewed by other research groups.[6], [10]–
[12] Table 1.2.1 summarizes the findings for various nanoparticle properties. In this
section, the role of these factors in biocorona formation and composition is presented
briefly.
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Fig 1.2.1: Important factors affecting the formation of biocorona classified under
nanoparticle properties and its surrounding environment.

Tables 1.2.1: Effect of various nanoparticle (NP) properties on biocorona. Reproduced
with permission from Nguyen et al. [1]

6

Surface curvature of nanoparticles (NPs) has been observed to affect the strength
of protein-protein interactions. Significant changes in composition and organization of
proteins in biocorona is also observed when nanoparticle size is comparable to the size of
the protein.[6] Size and curvature of NPs also seem to affect binding of proteins. For
instance, higher surface to volume ratio in gold nanomaterials of 30 nm diameter
adsorbed more proteins than 50 nm sized nanoparticles as reported by Dobrovolskaia et
al.[13] Proteins on gold nanoparticles were observed to by structurally changed
(unfolded) and indeed catalyze the formation of protein aggregates.
In addition to size and shape, defects that are inevitable in ENMs also play a role
in biocorona formation needs attention. Chapter 4 presents variations in biocorona due to
defects in carbon nanotubes in detail. Hydrophobic surfaces have been found to adsorb
more proteins compared to hydrophilic/ neutral surfaces. Proteins on hydrophobic ENMs
tend to unfold in order to accommodate more proteins. Albumin molecules have been
shown to adsorb more proteins on hydrophobic nanoparticles than hydrophilic
counterpart albeit protein affinity roughly remaining the same.[14]
Time evolution of biocorona on different sized (4-40 nm) gold nanoparticles was
carefully assessed by Casals and his group[15]. They stabilized these gold nanoparticles
by

coating

citrate,

mercaptoundecanoic

for

negative

surface

charge

and

aminoundecanethiol for a positive surface charge. NPs were exposed to cell culture
medium containing 10% fetal bovine serum (FBS). Also they observed irreversible
change in proteins over time, which confirm our present understanding. It has been
reported that protein adsorption increases with increase in surface charge of NPs.[16]
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Chapter 5 discusses Ag NPs (with various surface functional groups) and their interaction
with apolipoprotein to form corona.
Biological environment also plays a crucial role in coronal composition and
formation. Maiorano et al. experiments with citrate coated Au NPs with various cell
culture media determined how media composition influences NP-biomolecular corona
and cellular response.[17] They chose two widely used cell culture mediums DMEM and
RPMI with fetal bovine serum as the protein source. Biological impacts were evaluated
with several viability assays onto cell lines human epithelial cervical cancer (HeLa) and
human leukemic monocyte lymphoma (U937). Interestingly, they observed DMEM
induced stable and a protein-rich corona as compared to RPMI. This study confirmed
nanoparticle-protein complex formation mediated in physiological environment can
impact on cellular responses.

In summary, ENMs are useful for various applications including nanomedicine
due to their unique properties. However, a deeper understanding of ENM-induced
cytotoxic and inflammatory responses is needed before the viability of ENMs can be
realized. To this end, it is imperative to understand the dependence of ENM-biocorona on
ENM physicochemical properties including size, shape and surface functionality. This is
highly complex because all the physicochemical properties are interrelated. As it will be
discussed in the following chapters of this work, size, shape, surface charge, and defects
are important in the formation and evolution of ENM-biocorona while biocorona
formation itself can alter the charge and dispersion stability of the ENM system. The
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complex interdependence between biorocona and ENM physicochemical properties is
very hard to decouple in reality and is a major roadblock in the ability to predict ENM’s
toxic response based on its physicochemical properties.
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CHAPTER TWO
SPECTROSCOPIC CHARACTERIZATION TECHNIQUES

The advancement of nanotechnology over the past two decades has spurred the
fields of health care, information technology, energy, homeland security, food safety and
transportation; and the global market for nanotechnology-related products reached more
than $200 billion in 2009 with a projected $1 trillion per annum by 2015 (US Senate
Committee, 2011).[18] Despite this enormous global market, there remain several
concerns regarding the impact of engineered nanomaterials (ENMs) on biological
responses in living organisms, and the environment at large.[19]–[23] A comprehensive
knowledge of the ENM-biomolecular interactions is central to applications in
nanomedicine, consumer goods, and other unintentional exposures. Currently, there are
more than 40 nanopharmaceuticals in routine clinical use and the patents and publications
on nanomedicine have been exponentially increasing.[24] Considering that nanomedicine
efforts are a sudden convergence of contrasting scientific disciplines (e.g. viz., materials
science,

bioengineering,

pharmacology),

the

advancement

and

acceptance

of

nanotechnology relies heavily on a holistic interdisciplinary understanding of the impact
of fundamental properties of ENMs (such as their morphology, size, defects and chemical
stability) on physiological and environmental systems.
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Upon introduction into a biological system, ENMs rapidly associate a variety of
macromolecules including proteins, peptides, amino acids, fatty acids, lipids and other
organic matter forming protein biocorona. [25]–[27] The formation of the corona is not
only dictated by the physicochemical properties of the ENM but also the composition of
the physiological environment. [28] The addition of the corona on the surface of the
ENM imparts a new distinctive interactive surface, which influences activity, deposition,
clearance, and cytotoxicity. [29]–[31] The biocorona has also been shown to compromise
the targeting capacity of functionalized ENMs and subsequently hinder delivery therapy.
[27], [32], [33] In addition, the inconsistencies observed between in vitro to in vivo
extrapolation of ENM toxicity are likely contributable to differences in ENM-biocorona
formation. [25], [34] Spectroscopic tools are ideal for exploring the biological
interactions of ENMs with proteins.[6], [35], [10] As discussed in this chapter, combining
spectroscopic tools with traditional toxicological studies can provide unique insights into
the nano-bio interface that could be used to ultimately design benign ENMs.

2.1 Hyperspectral imaging

Gold and silver nanoparticles display a collective and resonant oscillation of
surface electrons, known as plasmons, upon light excitation in the visible region (400-700
nm).

The surface plasmon resonance is highly sensitive to both nanoparticles

aggregation and the dielectric constant of the environment surrounding them. In a
biological medium, the presence of protein corona around nanoparticles alters the SPR
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peak by modifying the dielectric constant. [36] Similarly, their cellular uptake could lead
to aggregation, which is known to red-shift the SPR peak. [37] Hyperspectral imaging is
an excellent tool that combines microscopy and spectroscopy in real time by
accumulating reflectance spectrum for each pixel in a micrograph. Thus, the state of
nanoparticles and protein corona upon cellular uptake can be gleaned from the
hyperspectral micrographs.[38]–[40] Recently, we explored the cellular uptake of silver
nanoparticles (Ag NPs) with and without protein corona using hyperspectral imaging.[41]
Our studies revealed intracellular modifications resulting from protein corona formation
as shown in Fig. 2.1.1. Changes in the microenvironment of AgNPs were evidently
reflected in the shift of plasmon energies allowing us to differentiate between intra- and
extra-cellular nanoparticles. Hyperspectral imaging presents an alternative to traditional
electron microscopy methods for the identification of nanoparticles and protein corona
inside the cell. [42]–[45]The exhaustive sample preparation needed for electron
microscopy, such as encapsulation in a polymer followed by microtoming, often leads to
artifacts. For example, the large agglomerates formed during the electron microscopy
sample preparation are indistinguishable from agglomerates resulting from the loss of
nanoparticles surface coating upon entering biological media.
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Figure 2.1.1: (a) Hyperspectral enhanced darkfield images of macrophages exposed to
AgNPs and AgNPs with protein corona for 2 h, at a concentration of 25μg/mL.
Macrophage nucleus appears blue in the images due to DAPI stain. (b) Differences in
mean spectra for AgNPs with different sizes (20 and 110 nm) and coatings (PVP and
citrate). Based on such shifts in plasmon energies, it is possible to study the uptake and
modification of AgNPs using hyperspectral imaging.

2.2 Circular dichroism spectroscopy

ENM-protein complex formation poses concerns on potential denaturation of
proteins, which can alter protein binding to receptors and induce inflammatory responses.
Lysozyme, for example, adsorbed on gold nanoparticles (AuNPs) were observed to
induce misfolded proteins which likely catalyze the formation of aggregates.[46]
Similarly, fibrinogen was found to unfold on the surface of stabilized (negatively charged
with polyacrylic acid) AuNPs, and bind to integrin receptor (MAC-I) leading to the
inflammatory response.[47] Circular dichroism (CD) spectroscopy has been extensively
used to study conformational changes in biomolecules.[48]–[50] CD studies on ENM
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protein corona can elucidate the changes in protein secondary structures ensuing from
their adsorption to ENMs surface.[51] For example, apolipoprotein (ApoA-I) protein,
which is known to be abundant in the protein corona of metal nanoparticles, exhibited
secondary structural changes dependent on the surface coating (Fig. 2.2.1). ApoA-I is the
major lipoprotein component of high-density lipoprotein (HDL). It adopts a shape similar
to a horseshoe of dimensions 12.5x8x4 nm with high α-helix content.[52]–[54] The
helices in ApoA-I are predicted to be amphipathic, with the hydrophobic (/hydrophilic)
face mediating lipid (/aqueous) interactions. The thermodynamic drive to minimize the
aqueous exposure of the hydrophobic residues is one of the major factors in ApoA-I
adsorption on AgNPs.[55], [56] We studied the interactions between ApoA-I and 100 nm
AgNPs with four different coatings viz., citrate, polyvinylpyrrolidone (PVP), branched
polyethyleneimine (bPEI) and lipoic acid.[57] These coatings were chosen to provide
both negative (citrate, PVP, lipoic acid) and positive charged surfaces (bPEI) with
different affinities for AgNPs. While lipoic acid interacts strongly through Ag-S bonds,
other coatings (citrate, PVP, bPEI) are considerably weaker. As shown in Fig. 2.2.1, CD
studies showed a significant decrease in α-helical content for all surface coatings with the
complete disappearance of α−helices for AgNP-bPEI and AgNP-lipoic acid. From a
physiological standpoint, we found a significant increase in the ability of ApoA-I coated
AgNP-bPEI and AgNP-lipoic acid to generate reactive oxygen species due to its
unfolding. The conformational changes observed in CD can provide more information on
ENM-protein corona complex and may even be used as a predictor of adverse immune
responses.
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Figure 2.2.1: (a) Circular dichroism (CD) spectra for ApoA-I incubated with AgNPs of
different surface coatings (citrate, PVP, bPEI, and lipoic acid) shows (b) marked decrease
in α-helix content with corresponding increase in β-sheets and irregular structures.
Spectra were analyzed using CAPITO (a CD Analysis & Plotting Tool) and secondary
structure content was estimated. CD spectroscopy provides secondary and tertiary protein
structure content estimation of biomolecules, which is critical for analyzing
conformational changes during ENM-protein interactions.

2.3 Infrared spectroscopy

Unlike metal nanoparticles, carbon-based ENMs exhibit strong optical absorption
<240 nm due to their π-electron system, which can interfere with protein CD spectra
collected in 200-300 nm range, precluding the use of CD to study nanocarbon-protein
corona. Alternatively, we used ATR-FTIR (attenuated total internal reflection- Fourier
transform infrared) spectroscopy to elucidate the adsorption-induced structural changes in
proteins (bovine serum albumin or BSA and fibrinogen) on carbon ENMs such as multi-
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walled carbon nanotubes (MWNTs), graphene and graphene oxide nanoribbons (GNRs
and GONRs). The FTIR spectrum of proteins displays two main bands, Amide I (16001700 cm-1) and Amide II (1500-1580 cm-1), arising from the amide bonds that link the
amino acids in proteins. While Amide I band is mainly associated with the C=O
stretching vibration, Amide II band results primarily from bending vibrations of the N—
H bond. Given that both the C=O and the N—H bonds are involved in the hydrogen
bonding between the different peptide units, their spectral position and intensity can be
used to determine the secondary structure content of a protein. For example, as shown in
Fig. 2.3.1, the α-helical content in BSA leads to strong adsorption ~1640-1660 cm-1
(dashed lines) while the lower frequency component at ~1620-1640 cm-1 and the peak
~1555 cm-1 arise from β-sheets. Clearly, the rich secondary structure of BSA
(particularly, the peak relating to α-helical content) significantly disappears upon its
adsorption on to all carbon-based NMs, as expected from its low internal stability.
Indeed, the changes in secondary structure are higher in the case of MWNTs (i.e.,
complete disappearance of secondary structure) suggesting that BSA unfolds much more,
relative to GNRs and GONRs, in order to adhere to the tubular MWNTs. GNR and
GONR retain BSA secondary structure to a certain extent, as shown by the presence of
~1555 cm-1 for β-sheets. In the case of fibrinogen, the secondary structural changes are
found to be higher for GONRs compared to MWNTs and GNRs plausibly due to the
formation of hydrogen bonds. The α-helix peak was found to partially disappear for
fibrinogen adsorbed on MWNTs and GNRs. Lastly, the structural changes for fibrinogen
on GNRs seemed to be less pronounced than MWNTs possibly due to its shape. It could
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be rationalized that fibrinogen must unfold more to adhere to MWNTs due to their higher
curvature than GNRs. To further understand NM-BSA interactions, we also performed
large-scale molecular dynamics (MD) simulations of BSA-MWNT, GNR/GONR-water
systems (detailed in [58]). As shown in Fig. 2.3.1, we observed that proteins undergo
conformational changes after initial contact (in accordance with our experimental
observations, discussed in Fig. 2.4.1) leading to some protein regions collapsing on to the
ENM surface rather than gradually spreading from the initial region of contact.

Figure 2.3.1: (a-c) Snapshots of MD simulations showing BSA on SWNT, GNR, and
GONR 10 ns after adsorption. (d-f) show the top-view. The adsorption is accompanied by
disruption of a-helices into random peptide chains (shown in orange).
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2.4 Electrochemical impedance spectroscopy

Charge transfer is known to play an important role in several many physiological
processes including blood clotting, vitamin absorption, and oxidative stress.[59]–[61]
Differences in electronegativity between proteins and the ENM surface may induce
charge transfer which, along with other perturbations in the media (e.g. pH,
thermodynamic fluctuations), plays a critical role in protein denaturation, protein-protein
interactions, and alterations to the cellular and extracellular redox status.

Such

interactions are not necessarily specific, with conformational changes possibly resulting
in newly exposed charged regions and hydrophobic domains attracting or repelling other
surrounding proteins or nanostructures. Electronic properties of ENMs including their
band structure and density of states have been shown to regulate protein adsorption
dynamics via charge transfer, which is evident as shifts in absorption and emission
spectra.[62], [63]

2.4.1 Charge transfer during corona formation

The chemisorption of proteins on bulk material surfaces has been known to occur
through charge transfer processes. For example, the aromatic amino acids present in BSA
(tryptophan, phenylalanine, histidine, and tyrosine) could interact with the unhybridized
pz orbitals of the carbon-based ENMs, via providing a weak acceptor level in the
electronic density of states (DOS) to allow partial charge transfer. It may be expected that
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a surface facilitating higher charge transfer at the nanoscale may lead to stronger surfaceprotein interactions and a subsequent increase in protein adsorption. Spectroscopic and
electrochemical techniques such as micro-Raman, CD, and cyclic voltammetry can be
used to analyze elucidate the influence of charge transfer on protein affinity for ENMs
and the alterations in secondary and tertiary structures that occur with adsorption. Among
the variety of ENMs, nanocarbons possess a strong affinity for proteins through
hydrophobic and aromatic π-π stacking interactions. [64] Previously, we elucidated the
charge transfer interactions between nanocarbons and proteins using micro-Raman
spectroscopy. Our results show strong interactions of proteins (albumin and fibrinogen)
with nanocarbons is strongly influenced by charge transfer between them, inducing
protein unfolding which enhances conformational entropy and higher protein adsorption.
For instance, the UV-visible absorption spectrum of single-wall carbon nanotubes
(SWNTs) coated with BSA was found to blue shift significantly while BSA-coated
graphene sheets (both exfoliated and synthesized via chemical vapor deposition)
exhibited no such changes.[65] Additionally, micro-Raman spectroscopy revealed
alterations in the structure of the G-band (or graphitic band) of BSA-coated SWNTs. The
G-band, which is highly sensitive to charge transfer, was found to be upshifted with a
Breit-Wigner-Fano lineshape resulting from electron transfer between BSA and SWNTs.
No changes were observed for graphene upon protein coating indicating that ENMs-BSA
charge transfer is unique to SWNTs.

Concomitantly, FTIR spectroscopy revealed

subsequent conformational changes in BSA (Figure 4) in the form of unfolding of α–
helices, suggesting hard corona formation on SWNTs as opposed to graphene. These
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results insinuate that disruption in electrostatics due to ENM-protein charge transfer leads
to the breaking of peripheral H-bonds in the α–helices and permanent denaturation of
BSA on SWNTs. [65], [66]

Figure 2.4.1: (a) FTIR spectra for native BSA, BSA-adsorbed on MWNTs, GNRs, and
GONRs show that the CNMs significantly affected the secondary structures of the
proteins. The absorption peak for α-helix in native BSA, in the range from 1640 to 1660
cm-1 (indicated by the vertical dashed lines), showed a significant reduction (disappeared
for MWNTs) for all CNMs suggesting that the secondary structure of BSA adsorbed on
CNMs was less compact. (b) In the case of fibrinogen, the loss of secondary structure
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was highest for GONRs possibly due to the formation of hydrogen bonds. While both
MWNTs and GNRs exhibited a loss of α-helical content, the appearance of new peak
~1500 cm-1 (corresponding to random motifs) in GNRs suggested a lesser degree of
relaxation for fibrinogen, compared to MWNTs
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CHAPTER THREE
EFFECT OF DEFECTS IN CARBON NANOTUBES ON CORONAL
COMPOSITION AND ITS FATE
Raghavendra, Achyut J., et al. "Variations in biocorona formation related to defects in the
structure of single walled carbon nanotubes and the hyperlipidemic disease
state." Scientific reports 7.1 (2017): 8382. Produced in part with permission of Nature
Publisher Group.
Bai, Wei, et al. "Defect density in multiwalled carbon nanotubes influences ovalbumin
adsorption
and
promotes
macrophage
activation
and
cD4+
T-cell
proliferation." International journal of nanomedicine 11 (2016): 4357. Reproduced in
part with permission of International Journal of Nanomedicine.

3.1 Introduction

Successful immunotherapy requires identification of target antigens, their
efficient delivery, and subsequent interaction with the antigen-presenting cells (APCs)
and T cells without eliciting negative regulatory immune suppression or rejection in the
host. Recently, a variety of cancer vaccines have been developed and tested in clinical
studies but only a few trials obtained >5-10% partial or complete response. This may be
attributed to the failure in vaccine formulation, targeted delivery, and consequent
activation of the immune system.[67], [68] Alternatively, antigen-coated microparticles
(e.g. 1 to 10 μm aluminum salts) have been widely used in both human and veterinary
vaccines to stimulate immune responses and improve the efficacy of vaccines but only
had limited success.[69] With the rapid development of nanotechnology, researchers
expect to build on the unique physicochemical properties of nanomaterials to provide
new alternatives for vaccine development.[70]
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Among a wide variety of nanomaterials, carbon nanotubes are one of the most
promising candidates for drug and antigen delivery due to their unique physicochemical
properties such as the high surface area to volume ratio and delocalized pi-electron cloud.
For example, recent studies have utilized CNTs to successfully deliver peptides[71],
cancer testis antigen[72], and small molecular drugs[73], in various in vitro immune cell
lines and in vivo animal models. CNTs are inherently hydrophobic and exhibit strong
tendency to aggregate in aqueous media, which limits their use in the biomedical
application. Accordingly, as-produced CNTs are often modified using wet chemical
methods for adding carboxyl and hydroxyl functionalities to improve their suspension
stability. Such surface modifications of CNTs are also known for reducing their toxicity
and improving their ability to modulate the immune system[74][75]. In addition, our
proteomics studies showed that carboxylated CNTs bind significantly more serum
proteins in cell culture media than pristine nanotubes.[76] Further, carboxylated CNTs
have been proposed for use in vaccine delivery due to their ability to bind protein. In
general, it appears that carboxylation of CNTs enhances their biomedical applicability.
However, during the process of carboxylation, surface defects are often introduced into
the CNTs and it is currently unclear how these surface defects will impact CNTs used in
biomedical applications such as antigen delivery for vaccines. Therefore, in this study,
we investigated two carboxylated MWCNTs with different levels of surface defects.
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In this work, we investigate the use of carboxylated multi-walled carbon
nanotubes (MWCNTs) with two different defect densities as a vaccine delivery vehicle to
deliver a specific antigen to stimulate the immune response. Carboxylated MWCNTs
were loaded with ovalbumin (OVA) and delivered to bone marrow derived macrophages.
These macrophages were co-cultured with OVA-specific CD4+ T cells isolated from OTII mice for 5 days. We demonstrated that OVA was abundantly absorbed on MWCNTs
and was efficiently delivered into macrophages without observable toxicity. Interestingly,
MWCNTs with higher defect density showed more OVA adsorption despite their low
surface area. We found that MWCNT-OVA complex significantly induced the secretion
of cytokines (TNFα and IL-6) and expression of MHC class II on macrophages as
compared to MWCNTs alone or OVA alone. Remarkably, OVA peptides were presented
on MHC class II and subsequently stimulated the robust proliferation of CD4+ T cells
after co-culture. In contrast, MWCNTs without OVA coating did not induce cytokine
production, expression of MHC class II, nor CD4+ T cell proliferation. Our work
provides strong evidence for use of MWCNTs as an antigen delivery system in vaccine
development.
Single walled carbon nanotubes (SWCNTs) are one-dimensional structures with
unique optical and electronic properties relevant for many biomedical applications.[77],
[78] Particularly, the sharp densities of electronic states at the so-called van Hove
singularities (vHS) in SWCNTs impart strong resonant optical absorption and emission
of visible and near-infrared light, which makes them invaluable for applications in
photothermal

therapy,

multimodal

imaging
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(e.g.,

Raman,

fluorescence

and

photoacoustic), and cancer drug delivery.[79], [80] While much research has focused on
exploiting SWCNT properties for biomedical applications, their toxicity has been well
demonstrated. Fundamental understanding of SWCNT biological interactions and
mechanisms of toxicity still, however, remain elusive.[81]
In physiological environments, cells interact with the biocorona (BC), which
consists of a layer of physi- and chemi-sorbed biomolecules (i.e. proteins, lipids,
peptides, etc.), which inadvertently accumulate on the surface of the SWCNTs.[82]–[84]
The addition of the BC alters not only the surface and properties of the SWCNT but may
also modify their cellular interactions similar to what has been shown with other
nanoparticles.[85]–[87] Ultimately this means that the BC can interfere with the
SWCNT’s function (viz., imaging or drug delivery), and alter its biodistribution,
clearance, and/or toxicity. It has been demonstrated that the physicochemical properties
of nanomaterials in general influence the formation and the content of BC, however, the
impact of structural defects have not been fully evaluated.[88], [89] The formation of BC
on SWCNTs, however, is more fundamentally intriguing due to the presence of vHS in
its electronic structure.
Previously, we showed that the vHS in SWCNTs leads to unexpected chargetransfer interactions with proteins such as fibrinogen and could lead to undesired
thrombosis.[65] The electronic structure of SWCNTs is highly sensitive to defects, which
are often unintentionally introduced in SWCNTs while processing them through
mechanical or chemical functionalization for biological applications.[90], [91] The
presence of defects alters SWCNT biomolecular interactions through charge-transfer
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interactions and could ultimately change the composition of BC. Understanding BC
compositional differences due to defects in SWCNTs will allow for new avenues of
control regarding BC formation to be explored resulting in regulation of biological
response.
To enable the safe and effective use of CNTs in nanotechnologies it is essential to
evaluate differences in the BC that forms under these increasingly prominent disease
states. In the current evaluation of the BC, we hypothesized that the defects in SWCNTs
will result in differential association of biomolecules forming the BC. Additionally, we
hypothesized that disease-associated differences in the physiological media would also
alter BC formation. To examine the role of defects and a high cholesterol environment
on the formation of the SWCNT-BC we utilized a quantitative proteomics approach with
label-free mass spectrometry. We prepared SWCNTs with different defects using a
planetary ball-milling approach. The defects in SWCNTs were characterized using a
comprehensive array of tools including transmission electron microscopy, Raman and
photoluminescence spectroscopy, and gas-adsorption isotherms. We observed that
increased ball-milling time of SWCNTs resulted in more defects introduced in the
structure of SWCNTs. Following incubation in normal mouse serum, quantitative labelfree mass spectrometry identified differences in the biomolecular content of the BC
resulting from the ball-milling process. Further, incubation in cholesterol-rich mouse
serum resulted in the formation of unique BCs compared to SWCNTs incubated in
normal serum. Ultimately our study demonstrates that the BC is modified due to
physicochemical modifications in SWCNT structure induced by ball-milling and due to
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physiological disease conditions. These alterations in the BC may result in variable
biological responses.

3.2 Materials and methods

3.2.1 Preparation and characterization of MWCNT-ovalbumin complex
Pristine MWCNTs with two different sizes were obtained from Cheap Tubes Inc,
including MWCNT-2 (10-20 nm, 0.5-2 μm) and MWCNT-30 (10-20 nm, 10-30 μm).
Pristine MWCNTs were carboxyl functionalized according to the previous method (17).
Size and morphology of carboxylated MWCNTs were evaluated by transmission electron
microscopy (TEM) using a Hitachi 7600 (Hitachi Group). Diameter and length
measurements were performed on  100 CNTs. Ovalbumin was purchased from Sigma
and dissolved in PBS at 1 mg/mL. To generate MWCNT-OVA complex, 200 μL of
carboxylated MWCNT (1 mg/mL), 500 μL of ovalbumin solution (1 mg/mL) and 700 μL
of distilled water were mixed and incubated on a rotator overnight at 4 °C. The mixture
was centrifuged (14,000 rpm, 10 min, 4°C) and the pellets were washed twice to remove
non-adsorbed ovalbumin. After wash, the pellets were re-suspended in distilled water at 1
mg/mL. The hydrodynamic size and zeta potential of either MWCNT or MWCNT-OVA
complex were determined using a Zetasizer Nano ZS (Malvern Instruments). The surface
area measurements were performed on a Quantachrome Autosorb iQ gas sorption
analyzer using N2 gas. Raman characterization of MWCNTs was performed using a
Renishaw InVia microscope coupled to 514.5 nm Ar+ laser.

27

To quantify the amount of ovalbumin bound to MWCNTs, the mixture used for
the formation of MWCNT-OVA complex was centrifuged (14,000 rpm, 10 min, 4°C) and
the supernatant was collected. The concentration of ovalbumin in the supernatant was
determined by Pierce BCA protein assay, which was subtracted from the initial
concentration of ovalbumin in the original mixture to calculate the amount of ovalbumin
bound to MWCNT. The measurement was conducted at least three times.

3.2.2 Synthesis and characterization of SWCNTs.
SWCNTs were prepared using chemical vapor deposition.27 An MTI planetary
ball mill was used to induce defects in SWCNTs. High-resolution transmission electron
micrographs were obtained using Hitachi H-9600. A Renishaw InVia micro-Raman
(coupled to 514.5 nm Ar+ laser) and Bruker IFS V/66 FT-Raman equipped with
Nd:YAG 1064 nm was used to obtain the Raman and PL spectra of SWCNTs. The
surface area of SWCNTs was characterized using Quantachrome Autosorb instrument.
All the spectroscopic measurements were performed in triplicates.

3.2.3 Animals and cell models
Male C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor,
ME) at 8-10 weeks of age. Breeding colonies of OT-II transgenic mice were also
acquired from The Jackson Laboratory (Bar Harbor, ME), and maintained in the animal
facility at the University of Colorado-Anschutz Medical Campus. OT-II transgenic mice
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express the mouse alpha-chain and beta-chain T cell receptor that pairs with the CD4+ coreceptor and is specific for chicken ovalbumin peptides (OVA323-339). All animal
procedures were performed with approval and in accordance with the guidelines of the
University of Colorado-Anschutz Medical Campus Institutional Animal Care and Use
Committee.
Male C57BL/6J mice were sacrificed and the femur bones were collected. Bone
marrow cells were flushed aseptically from the dissected femurs using a 25-gauge needle.
The cells were incubated in RPMI 1640 medium supplemented with 10% fetal bovine
serum (FBS), 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine, 1 mM
sodium pyruvate, 5 μM 2-mercaptoethanol, which is referred to the complete medium.
And the complete medium was supplemented with 10 ng/mL recombinant mouse
macrophage-colony stimulating factor (M-CSF, R&D systems, Minneapolis, MN). The
cells were incubated in a humidified incubator at 37 °C in 5% CO2. On Day 4, the
medium was replaced with complete medium supplemented with 5 ng/mL M-CSF. Bone
marrow derived macrophages were used following 7 days of culture and were found to be
>90% macrophages by expression of F4/80 antigen using monoclonal anti-mouse PerCPCyanine5.5-conjugated F4/80 antibody (eBioscience, Inc).
On the same day when macrophages were treated with MWCNTs, OT-II
transgenic mice were sacrificed and the spleen was collected. A single cell suspension of
splenocytes was obtained using a tissue dissociator (Miltenyi Biotec, Inc.), and red blood
cells were removed from the splenocytes using Mouse Erythrocyte Lysing Kit (R&D,
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Systems). CD4+ T cells were enriched using mouse CD4+ T Cell Enrichment Column Kit
according to the manufacturer’s procedure (R&D, Systems).
We employed fluorescent Texas Red-conjugated ovalbumin (TR-OVA) to form
MWCNT-TR-OVA complex to confirm the successful delivery of MWCNT-OVA
complex into macrophages using enhanced darkfield fluorescent imaging microscopy
(Cytoviva, Inc. Auburn, AL). Macrophages were treated with 25 μg/mL of either
MWCNT or MWCNT-TR-OVA complex in chamber slides using the serum-free
medium. The use of serum-free DMEM is to prevent the binding of additional serum
proteins to either MWCNTs or MWCNT-OVA complex. Following 6 h exposure,
macrophages were washed with PBS and fixed with 4% paraformaldehyde for 10 min at
room temperature. The nuclei were stained with DAPI. The cells were imaged using
enhanced darkfield fluorescent microscopy (Cytoviva). The experiments were repeated at
least three times.
Macrophages were treated with 25 μg/mL of either MWCNTs or MWCNT-OVA
complex for 6 hours and were washed and incubated up to 5 days in complete medium
supplemented with 5 ng/mL M-CSF. On Day 1, Day 3 and Day 5, the supernatants were
collected for measurement of TNFα and IL-6 production using ELISA according to the
manufacturer’s protocol (R&D systems). For MHC class II expression, macrophages
were detached using 0.025% trypsin and re-suspended in staining buffer (Invitrogen). Rat
monoclonal PE/Cy5-conjugated anti-MHC class II (PE/Cy5) antibody (Abcam) was used
to detect MHC class II expression on macrophages using flow cytometry. Prior to
labeling MHC class II molecules, macrophages were pre-incubated with purified anti-
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mouse CD16/CD32 mAb (BD Pharmingen) to reduce Fc receptor-mediated nonspecific
binding. Ovalbumin was used as a positive control. The experiments were conducted
independently on a minimum of three different batches of BMDMs.
In order to investigate if the ovalbumin delivered by MWCNTs has the ability to
stimulate CD4+ T cell proliferation, CFSE-labeled CD4+ T cells were co-cultured with
macrophages loaded with MWCNT-OVA complex for 5 days. Briefly, macrophages
were treated with 25 μg/mL of either MWCNTs or MWCNT-OVA complex in the
serum-free medium for 6 hours, and were washed and co-cultured with CD4+ T cells
labeled with the fluorescent dye 5,6-carboxyfluorescein diacetate succinimidyl ester
(CFSE) (Thermo Fisher Scientific) for 5 days in the complete medium supplemented with
5 ng/mL M-CSF. The ratio of T cells to macrophages was 2:1. After 5-day co-culture,
both macrophages and CD4+ T cells were detached using 0.025% trypsin and resuspended in the staining buffer. CD4+ T cells were then immunostained with APCconjugated mouse anti-CD4+ antibody (eBioscience) to distinguish them from
macrophages. The proliferation of CFSE-labeled CD4+ T cells by CFSE dilution was
analyzed using flow cytometry (AccuriTM C6 Flow Cytometer, BD Biosciences, Ann
Arbor, MI) and FCS Express 4 software (De Novo Software, Glendale, CA). The
experiments were repeated at least three times.
All graphs and statistical analysis were performed using Prism 6 software
(GraphPad, San Diego, CA). Statistical significance was analyzed by one-way analysis of
variance (ANOVA) with differences between groups assessed using Dunnett’s post hoc
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tests. Differences were considered statistically significant when p < 0.05. Refer Chapter
4.2.5 section for methods on formation and evaluation of SWCNT-biocoronas.

3.3 Results and discussion

3.3.1 Case of MWCNTs

Figure 3.3.1: TEM analysis of carboxylated MWCNT-2 (A) and MWCNT-30 (B). The
outer diameters of carboxylated MWCNT-2 and MWCNT-30 were 26 ± 5 nm and 18 ± 3
nm, respectively. The average length of both carboxylated MWCNTs was ~500 nm.

As Fig. 3.3.1 shows TEM images of two carboxylated MWCNTs in their dry
state. The size analysis indicated that the outer diameters of carboxylated MWCNT-2 and
MWCNT-30 were 26±5 nm and 18±3 nm, respectively, which are roughly consistent
with the manufacturer specifications. The average length of both carboxylated MWCNTs
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was found to be ~500 nm, which is much shorter than the manufacturer specifications.
We surmise that the functionalization process for adding carboxyl groups resulted in the
observed reduction in length due to breaking at the defect site.[92] Our gas sorption
measurements showed that the MWCNT-2 and MWCNT-30 samples have surface areas
~215 m2/g and 94 m2/g, respectively. The Raman spectra of MWCNT-2 and MWCNT-30
showed the presence of the so-called disorder or D-band (~1350 cm-1) along with the
characteristic graphitic or G-band (~1580 cm-1) (Fig. 3.3.2). Both the samples also
exhibited at a higher frequency shoulder to the G-band (known as the D’ band ~1620 cm1

) suggesting high defect densities in the samples. The ratio of D- to- G band areas (ID/IG)

was calculated to be 0.97±0.1 and 1.37±0.2 for MWCNT-2 and MWCNT-30,
respectively, showing that MWCNT-30 samples contain more defects.
To understand the ability of MWCNTs to deliver ovalbumin, it is important to
quantitatively determine the amount of ovalbumin bound to MWCNTs. The amount of
ovalbumin bound to MWCNT-2 and MWCNT-30 was 582 ± 41 μg/mL (~0.582 mg OVA
per 1 g CNTs, 0.271 ng OVA per cm2 of CNTs) and 1066 ± 182 μg/mL (~1.066 mg OVA
per 1 g CNTs, 1.12 ng OVA per cm2 of CNTs), respectively. This difference may be
rationalized in terms of higher defect density (as seen from Raman spectra in Fig. 3.3.2)
in the case of MWCNT-30 samples. Such an observation is in agreement with our
previous experimental and theoretical studies, which show that the defects strongly
influenced biomolecular adsorption.[91]
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Figure 3.3.2: The Raman spectra of carboxylated MWCNT-2 and MWCNT-30. The Dband (~1350 cm-1) was found along with the characteristic G-band (~1580 cm-1). Both
MWCNTs also exhibited at a higher frequency shoulder to the G-band (known as the D’
band ~1620 cm-1) suggesting high defect densities in MWCNTs. The ratio of D- to- G
band areas (ID/IG) was 0.97 and 1.37 for MWCNT-2 and MWCNT-30, respectively,
indicating that MWCNT-30 samples contain more defects.
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Figure 3.3.3: Effects of ovalbumin coating on the hydrodynamic size and zeta potential
of MWCNTs. (A) Ovalbumin coating increased the hydrodynamic size of MWCNTs (A)
but had little impact on the zeta potential of MWCNTs (B). (n=3, mean ± SD, * p>0.05
comparison between MWCNTs with and without ovalbumin coating)

TEM characterization showed the length of MWCNTs in a dry state, however,
MWCNTs undergo a certain degree of agglomeration upon dispersion. We measured the
hydrodynamic size and zeta potential of MWCNTs using dynamic light scattering (DLS).
DLS measurement showed the similar hydrodynamic size (~200 nm) of MWCNT-2 and
MWCNT-30 due to agglomeration (Fig. 3.3.3A). As expected, MWCNT-OVA complex
showed a significant increase in hydrodynamic size than uncoated MWCNTs. Ovalbumin
coating increased the size of MWCNT-30 to a greater degree than MWCNT-2 (Figure
3A) concomitant with the amount of bound ovalbumin. In addition, though both
MWCNT-2 and MWCNT-30 have the similar zeta potential (Fig. 3.3.3B), we found that
ovalbumin coating slightly decreased the zeta potential of MWCNT-30 (Fig. 3.3.3B) but
not MWCNT-2 resulting in a more negatively charged MWCNT-30.
We used photoluminescence (PL) spectroscopy to study the effect of defects on
the adsorption of ovalbumin on MWCNTs. The aromatic amino acid content in OVA
absorbs light strongly at ~280 nm and emits at ~338 nm, and a standard curve was
established in terms of the intensity of the emission peak (~338 nm) in OVA (Fig.
3.3.4A). We observed clear differences between all MWCNT-2 and MWCNT-30
samples in both pristine and functionalized forms (Fig. 3.3.4B and 3.3.4C). Indeed, in the
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case of MWCNT-30, we found that OVA adsorption deviates from a linear trend (shown
by the dashed black line in Fig. 3.3.4B and 3.3.4C) at higher concentrations. On the
other hand, MWCNT-2 exhibited Langmuir-like isotherm (see inset in Fig. 3.3.4B) in
both pristine and carboxylated forms. The results indicated that while carboxylated
MWCNT-2 and MWCNT-30 showed similar adsorption at lower concentrations, both
trends deviated from linearity albeit in different directions (shown by dashed black line)
at higher concentrations.

Figure 3.3.4: Binding of OVA to MWCNTs confirmed by photoluminescence
spectroscopy.
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To demonstrate the successful delivery of ovalbumin by MWCNTs into
macrophages, we employed darkfield microscopy in conjunction with fluorescent Texas
Red-conjugated ovalbumin to confirm the uptake of MWCNT-TR-OVA complex by
macrophages (Fig. 3.3.5). After 6 h treatment, macrophages treated with or without
MWCNTs alone did not show any fluorescence. In comparison, macrophages treated
with ovalbumin showed fluorescence, and most interestingly, macrophages treated with
MWCNT-TR-OVA complex displayed strong fluorescence, suggesting that both
MWCNT-2 (Fig. 3.3.5) and MWCNT-30 successfully delivered ovalbumin into
macrophages.
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Figure 3.3.5: Delivery of fluorescent Texas Red-conjugated ovalbumin by MWNCT-2
into bone marrow derived macrophages (BMDM) visualized by darkfield and fluorescent
microscopy. Macrophages with or without treatment with MWCNTs alone showed no
fluorescence, but macrophages treated with ovalbumin and MWCNT-TR-OVA complex
displayed strong fluorescence. (Magnification: 100 X)
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We found that neither MWCNTs nor MWCNT-OVA complex had an impact on
cell viability of macrophages up to 5 days using MTS assay (Fig. 3.3.6). We further
investigated whether MWCNT-OVA complex activated macrophages. Classically
activated macrophages are characterized by the production of pro-inflammatory
cytokines, such as TNFα and IL-6, and the expression of MHC class II.[93] Ovalbumin
alone remarkably induced the production of both TNFα and IL-6 up to 5 days after
treatment while MWCNT-2 and MWCNT-30 alone had no effect on the production of
TNFα and IL-6 by macrophages (Ref. [94]). Interestingly, both MWCNT-2-OVA and
MWCNT-30-OVA complexes induced significantly higher production of both TNFα and
IL-6 after treatment compared to ovalbumin treatment alone. Importantly, MWCNT-30OVA complex induced a greater cytokine production compared to MWCNT-2-OVA
complex due to higher OVA adsorption.
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200
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MWCNT-2-OVA
MWCNT-30
MWCNT-30-OVA

150
100
50
0
Day 1

Day 3

Day 5

Figure 3.3.6: Effects of MWCNTs or MWCNT-OVA complex on cellular viability of
BMDM using MTS assay (n=6, mean ± SD). MWCNTs or MWCNT-OVA complex
showed no observable effect on the cellular viability of macrophages up to 5 days.
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As demonstrated above, macrophages were effectively activated by MWCNTOVA complexes. Therefore, we further investigated whether these activated
macrophages, in turn, enhanced CD4+ T cell proliferation using ovalbumin-specific CD4+
T cells isolated from OT-II mice. We co-cultured CFSE-labeled OT-II CD4+ T cells with
macrophages treated with either MWCNTs or MWCNT-OVA complex. As expected,
ovalbumin alone induced CD4+ T cell proliferation (Fig. 3.3.7A). Interestingly, we found
that both MWCNT-2-OVA complex and MWCNT-30-OVA complex significantly
induced the proliferation of CD4+ T cells, but MWCNT alone had no impact on CD4+ T
cell proliferation (Fig. 3.3.7B and C). We also found that MWCNT-30-OVA complex
induced greater CD4+ T cell proliferation than MWCNT-2-OVA complex, supported by
the observation that there were six distinguished generations of CD4+ T cells with
MWCNT-30-OVA complex, but only 4 with the others (ovalbumin or MWCNT-2-OVA
complex).

40

Figure 3.3.7: MWCNT-OVA complex remarkably induced CD4+ T cell proliferation.
(A) Proliferation of OT-II CD4+ T cells after co-culture with untreated macrophages
(black line) and ovalbumin-treated macrophages (red line), (B) proliferation of OT-II
CD4+ T cells after co-culture with macrophages treated with MWCNT-2 (black line) and
MWCNT-2-OVA complex (red line), and (C) proliferation of OT-II CD4+ T cells after
co-culture with macrophages treated with MWCNT-30 (black line) and MWCNT-30OVA complex (red line).

3.3.2 Case of single-walled carbon nanotubes
SWCNTs were generated using a previously described chemical vapor deposition
(CVD) process.[95] The Raman spectrum of SWCNTs displays a unique radial breathing
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mode (RBM), which could be used to accurately determine the diameter distribution. As
shown in Fig. 3.3.8A, the Raman spectra of as-prepared SWCNTs at two excitation
wavelengths (514.5 and 1064 nm) showed RBMs between 150-180 cm-1 indicating a
sharp diameter distribution ~1.3-1.6 nm. Ball milling is expected to induce structural
defects by opening SWCNT end caps in addition to creating atomic vacancies and nonhexagonal rings in SWCNTs. Indeed, it has been previously shown that intensive ball
milling for ~50 h completely disrupts SWCNT tubular structure leading to multi-layered
polyaromatic carbon materials.[96] Accordingly, the ball milling time in this study was
limited to ~8 h to induce defects while retaining the tubular structure of SWCNTs. The
Raman spectrum of SWCNTs also was used to quantify the defect density based on the
ratio of the disorder (or D-band) to graphitic band (or G-band) intensity (Fig. 3.3.8B).
From Fig. 3.3.8B and C, it is evident that the D-to-G band intensity ratio (ID/IG) increased
with increasing ball milling time from 0.16 in as-prepared SWCNTs to ~1.5 in 8 h ball
milled samples. While SWCNTs ball milled for 2 h showed a rapid increase in ID/IG ratio,
higher ball milling times (4, 6, and 8 h) led to monotonic increase that appeared to be
saturated ~8 h (Figure 1B: ID / IG Ratio). All ball milled SWCNTs were found to retain
their tubular structure, as evidenced by the photoluminescence (PL) spectra and TEM
(Fig. 3.3.8C). The presence of the van Hove singularities (vHS) in SWCNT-electronic
density of states results in strong PL emission in the infrared region.29 As shown in Fig.
3.3.8C, a strong PL emission was observed for all SWCNTs ~1560 nm when excited at
1064 nm. This observation suggests that the one-dimensional tubular structure of
SWCNTs, necessary for the presence of vHS, was retained in all the ball milled samples.
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The ball milling process is known to increase the specific surface area of SWCNTs
through structural defects. To ascertain such changes in surface area, N2 gas adsorption
experiments were performed. The surface area was found to have a monotonic increase
with ball milling time up to 6 h (Table 3.3.1). Indeed, the surface area for 6 h ball milled
SWCNTs was found to increase by almost an order of magnitude. The significant
decrease in surface area of 8 h-ball milled SWCNTs could be attributed to the formation
of amorphous carbon that gets compacted during the milling process.
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Figure 3.3.8: A. Radial breathing modes from the Raman spectra of As Prepared
SWCNTs suggest a diameter distribution ~1.4 nm. The spectra were collected using both
514 and 1064 nm to probe all SWCNT populations. B. Alterations in the defect band (Dband ~1350 cm-1) in ball milled SWCNTs evidenced by their Raman spectra. All the
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spectra were normalized to the graphitic or G-band to obtain the ID/IG ratio that is
indicative of the defect density. Also, plot of ID/IG vs. duration of ball milling (inset)
shows that there is an initial rapid increase for 2 h ball milling followed by a saturation in
the defects with increasing ball milling time. The spectra shown in A and B are averaged
over at least three different sets. C. The photoluminescence spectra of As Prepared and
ball milled SWCNTs showed an emission peak ~1560 nm. The presence of strong
emission, unique to the tubular structure of SWCNTs, confirms that the defects were
introduced while still retaining the tubular morphology. All characterization experiments
were performed with an n ≥ 3.

SWCNTs

Surface Area

As Prepared

169.668 m /g

2 h ball milled

301.728 m /g

4 h ball milled

351.015 m /g

6 h ball milled

1091.402 m /g

8 h ball milled

118.165 m /g

2

2

2

2

2

Table 3.3.1: Alterations in the surface area of SWCNTs due to ball milling measured by
BET analysis.
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Serum from mice fed a normal western diet were collected to evaluate the
biocoronas that formed on SWCNTs. Specifically, following incubation in 10% normal
serum, individual biocoronal proteins on SWCNTs were identified utilizing label-free
mass spectrometry. This approach allowed for the identification of specific proteins
included in the biocoronas of SWCNTs following incubation in normal serum. Following
identification and assessment of relative quantitative differences between protein
components of the biocorona we evaluated alterations in the biocorona due to ball milling
(As Prepared vs Ball milled in normal serum). These comparisons for investigation were
determined based on the common processing of SWCNTs by ball milling for
manufacturing and the significant portion of our population that exist with
hyperlipidemia.

Ultimately,

these

comparisons

describe

differential

interactions that may occur due to typical alterations in SWCNT structure.
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biological

Figure 3.3.9: Venn diagrams representing the number of proteins found to associate
with SWCNTs following incubation in 10% normal serum comparing As Prepared
SWCNTs to SWCNTs that have undergone ball milling.

Ball milling of SWCNTs is a typical technique utilized in manufacturing that will
likely alter biomolecule interactions. To evaluate these ball-milled induced changes we
compared the protein components of the biocorona following incubation in normal
serum. The identity of the majority of proteins forming the normal biocorona was found
to be unchanged due to ball milling (Fig. 3.3.9). These commonly identified proteins that
did not vary due to ball milling included alpha-2-HS-glycoprotein, complement C3,
fibrinogen, fibronectin, plasminogen, serum albumin and others in the normal biocorona.
These proteins are similar to our evaluations in Chapter 4 of the proteins of the biocorona
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that form on multi-walled carbon nanotubes of differing characteristics and Fe3O4
nanoparticles. These shared proteins are likely associated with the engineered
nanoparticles due to their relatively high abundance in serum. Although many proteins
found to associate with SWCNTs were common between as-prepared SWCNTs and ball
milled samples, there were a number of unique protein components within each BC.
Specifically, ball milling, in general, resulted in the association of platelet-like factor 4,
serum amyloid, carboxylesterase 1C, metalloproteinase inhibitor and others during
incubation in normal serum. Ball milling also resulted in the unique association of
apolipoprotein B-100, platelet-like factor 4, glutathione peroxidase, phospholipid transfer
protein, alpha-2 antiplasmin and others during incubation in hyperlipidemic serum.
Interestingly, many proteins unique to the biocorona of ball milled SWCNTs in normal
serum, are known to function through redox and charge transfer mechanisms. For
instance, glutathione peroxidase converts H2O2 into water through charge transfer
reaction while metalloproteinase inhibitors chelate metal ions.[97] Upon ball milling, the
defects created in SWCNTs are often charged with exoelectrons and the Ni catalyst used
in SWCNTs synthesis may be exposed, unlike as-prepared SWCNTs.[98] It is plausible
that the charged defects and exposed metal catalyst increased the affinity for unique
proteins observed in the biocorona.
Further, for samples incubated in normal serum, fewer proteins were found to be
in common between As-Prepared and ball milled samples as the length of ball milling
time was extended (Figure 3.3.9). This suggests that a more diverse biocorona may form
on the surface of SWCNTs as a result of ball milling since fewer proteins are found in
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common as ball milling time is increased. While the majority of proteins identified were
found to be in common between As Prepared and ball milled samples it is likely that
these minor changes in protein identity may influence biological responses as shown in
the literature with silver nanoparticles. For example, serum albumin is the primary
component of the biocorona that forms on silver nanoparticles due to its abundance.
However, when the inflammatory response by macrophages was evaluated following
exposure to either silver nanoparticles with a biocorona that only consisted of albumin or
a complex biocorona differences were evident.[99] This suggests that minor changes in
the identity of the biocorona can elicit significant changes in biological responses.

Figure 3.3.10: Relative abundance of proteins found to associate with 2h ball milled
SWCNTs compared to As Prepared SWCNTs in normal serum.
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Figure 3.3.11: Differences in relative abundance of specific proteins (Transthyretin,
Clusterin, Complement C1q Subcomponent Subunit B, and Alpha-2-HS-Glycoprotein)
found to associate with SWCNTs in either normal serum due to ball milling time. All
ratios are As Prepared SWCNTs : Ball Milled SWCNTs.

Many common individual protein components were identified in the biocoronas
therefore, we next quantitatively evaluated whether ball milling influences their
abundance in the SWCNT biocorona. Differences in abundance were evaluated for
proteins found in common between As Prepared and ball milled SWCNTs following
incubation in normal serum. Representative data comparing the abundance of commonly
associated proteins between As Prepared and 2h ball milled SWCNTs following
incubation in normal serum is shown in Fig. 3.3.10. Ball milling resulted in the decreased
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abundance of many of these common proteins (higher ratios of As Prepared : 2h ball
milled). The abundance of many proteins associated with the complement system was
altered in the biocorona that formed on 2h ball milled SWCNTs compared to As Prepared
SWCNTs in normal serum suggesting modified interactions with the complement system.
The complement system is a part of the innate immune system and is involved in the
removal of foreign objects as well as the inflammatory response.[100] These alterations
in the interactions with the complement system due to ball milling may result in modified
activation of the immune system thereby altering the SWCNT inflammatory response and
clearance. These findings imply that ball milled SWCNTs are less likely to interfere with
the adaptive immune response and less likely to trigger an immune response. Although
many proteins were determined to commonly associate with SWCNTs, ball milling
influenced their abundance within the biocorona and may ultimately influence cellular
responses.
Progressive alterations in individual protein abundance due to ball milling time
were also analyzed (Fig. 3.3.11). For example, as ball milling time increased, the amount
of transthyretin was found to decrease on the surface of SWCNTs following incubation in
normal serum. Transthyretin is produced by the liver and is a carrier of the thyroidderived hormone thyroxine which is responsible for metabolism regulation.[101] Our
data suggest that As Prepared SWCNTs may result in increased disruption of the
endocrine system by binding transthyretin and interfering with the transport of thyroxine
as compared to Ball Milled SWCNTs. In addition, increased ball milling time led to the
increased association of clusterin (molecular chaperone protein and lipid transport) 32 and
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complement C1q subcomponent subunit B (complement cascade) following incubation in
normal serum. Increased ball milling time corresponded to decreased association of
alpha-2-HS-glycoprotein abundance following incubation in normal serum. Since alpha2-HS-glycoprotein is a large and abundant protein in serum it is likely that as its
association decreases in the biocorona it is being replaced by smaller and lesser abundant
proteins. This enrichment of lesser abundant proteins may alter the cellular interactions
of the biocorona.

Ultimately, these representative changes in commonly associated

individual protein abundance demonstrate differences in the biocorona of the SWCNT
that are dependent on the process of ball milling. These abundance changes and
alterations in protein identities support differential biological interactions due to ball
milling and the likelihood of variable cellular and physiological responses.
Proteins found to associate with As Prepared and Ball Milled SWCNTs incubated
in either normal serum were evaluated for biological pathways and common protein
characteristics via gene ontology. This assessment of the data was performed to examine
specific pathways and protein characteristics which may be potentially altered due to ball
milling of SWCNTs. As Prepared SWCNTs incubated in normal serum interacted with
biological pathways including blood coagulation, plasminogen activating cascade,
Huntington’s disease, integrin signaling pathway and others. Following ball milling
SWCNTs incubated in normal serum associated unique proteins which were related to
blood coagulation, plasminogen activating cascade, inflammation mediated by
chemokine and cytokine signaling and others. Overall the unique proteins which
associated with SWCNTs following ball milling only added more proteins to pathways
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already identified in the As Prepared sample. This suggests that ball milling increases the
interactions with pathways SWCNTs already may perturb prior to ball milling. Ball
milling resulted in the increased association of proteins related to the biological pathways
of blood coagulation, integrin signaling, plasminogen activating cascade. The process of
ball milling also resulted in interactions with proteins related to unique pathways
compared to the As Prepared sample.
To examine commonalities between proteins that associate with the surface of
SWCNTs and the role of ball milling, gene ontology was again utilized to assess protein
classes. In normal serum, As Prepared SWCNTs associated protein classes involved in
enzyme modulation, transfer/carrier, hydrolase, defense/immunity, signaling, receptor
and others. Following ball milling and incubation in normal serum SWCNTs associated
an increased number of distinct proteins related to enzyme modulation, transfer/carrier,
defense/immunity, signaling, and hydrolase. Following ball milling SWCNTs also began
to interact with proteins classified as structural. Following the process of ball milling,
additional numbers of unique proteins from classes of enzyme modulation,
transfer/carrier, defense/immunity, signaling, and cytoskeletal were found to associate.
These findings demonstrate that following ball milling SWCNTs incubated in normal
serum interact with the same classes of proteins as the As Prepared SWCNTs. The unique
proteins found to interact with SWCNTs following ball milling (Fig. 3.3.10) consist of
additional proteins from these classes. Ball milling, however, appears to increase
interactions with structural proteins.
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3.4 Conclusions

Defects in nanomaterials can play an important role in determining biomolecular
interactions with serum proteins. SWCNTs with different defect densities were prepared
by the ball milling process to study the influence of defects on biocorona formation. Our
study demonstrates that charged defects induced by the ball milling process result in the
formation of distinctive biocoronas through the differential association of proteins.
Specifically, proteins that function through charge transfer and redox mechanisms were
observed to bind defected SWCNTs.
Also, we demonstrated that carboxylated MWCNTs displayed no observable
toxicity to bone marrow-derived macrophages. Rather, an increase in MWCNT defect
density promoted protein binding leading to successful delivery of ovalbumin into
macrophages and promoted CD4+ T cell proliferation. Taken together, these data suggest
that in addition to surface modification such as carboxylation, surface defect density
should be considered in the design of novel carbon nanotube platforms for vaccine
delivery.
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CHAPTER FOUR
DISEASE INDUCED DISPARITIES IN CORONA FORMATION
Shannahan, Jonathan H., et al. "From the cover: disease-induced disparities in formation
of the nanoparticle-biocorona and the toxicological consequences." Toxicological
Sciences152.2 (2016): 406-416. Reproduced in part with permission of Toxicological
Sciences.
Raghavendra, Achyut J., et al. "Variations in biocorona formation related to defects in the
structure of single walled carbon nanotubes and the hyperlipidemic disease
state." Scientific reports 7.1 (2017): 8382. Produced in part with permission of Nature
Publisher group.

4.1 Introduction

Many of the nanotherapeutics being developed utilize intravenous delivery
thereby leading to direct vascular exposure of nanoparticles. However, it is becoming
recognized that exposure to NPs in animal models induces a variety of vascular effects
including exacerbation of atherosclerotic plaque formation, vascular inflammation,
oxidative stress, and modified vascular reactivity [102]–[106]. In general, cardiovascular
toxicity is of concern regarding the development of NPs and other pharmaceuticals as it is
often difficult to identify in early toxicity screens and represents a major cause of new
drugs failing phase II and III clinical studies. The improvement and development of in
vitro approach to screen NPs for cardiovascular toxicity prior to in vivo testing is
therefore needed.

A key to this improvement is the necessity that these in vitro

approaches accurately depict the in vivo environment.
A large and growing portion of the population currently exists with an underlying
disease state. These underlying disease states, such as cardiopulmonary diseases, can
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modify how individuals respond to exposures resulting in exacerbated responses[107]–
[109]. Hyperlipidemia is a significant underlying disease state that is common in a
significant portion of the U.S. population. Despite many common underlying disease
states, such as hyperlipidemia within the population, the majority of studies assessing
NP-induced toxicity are performed in healthy animal models and utilize in vitro models
representing healthy physiological conditions. These healthy scenarios often do not
represent the population in which nano-based therapeutics and diagnostic tools will be
utilized. Many diseases such as hyperlipidemia result in altered expression of circulating
macromolecules such as proteins, peptides, and lipids[110], [111].

Once NPs are

introduced into a physiological environment they are rapidly coated with macromolecules
forming a biocorona (BC)[82], [112]. The addition of the BC alters the interactive
interface of the NP and can thereby result in modified NP clearance, distribution, activity,
and toxicity[113]–[115], [17]. Variations in the BC resulting from using dissimilar in
vitro methods and the use of conditions that do not account for diseased physiological
environments that modify serum content may explain many inconsistencies between in
vitro toxicity screening and in vivo studies of NP safety[116] (Joris 2013). Therefore, the
formation of the BC is governed by the physicochemical properties of the NP, as well as,
the physiological environment [117], [9], [76], [118]–[120]. To date, the examination of
the toxicological impact of the BC has been performed only assessing the
physicochemical properties of the NP while ignoring the role of the physiological
environment and disease related changes in the biological milieu.
Magnetite, iron oxide (Fe3O4) NPs, are of considerable interest for their
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biomedical applications, particularly for their use as MRI contrast agents due to their
superparamagnetic properties[121]. Furthermore, their surfaces are easily modified to
allow for targeting of particular tissues, specifically for tumor targeting [122]. Due to
their emerging use in the biomedical field, evaluation of their toxicity is needed
particularly in individuals with underlying disease states that may influence the formation
of the BC. Additionally, the BC has been shown to influence the function of Fe3O4 NPs
by interfering with their contrast abilities when used for MRI [123]. It is unclear how
differential BC formation on the surface of Fe3O4 NPs due to disease-induced alterations
in serum content may affect functionality and toxicity.
In our current study, we evaluated the formation of the BC on Fe3O4 NPs using
normal/healthy and lipid-rich rat serum. This evaluation assessed changes in NP
physicochemical properties due to additions of the BCs as well as utilized a proteomic
approach to identify differences in the protein content of the BCs. Lastly, we assessed the
toxicological implications of these BCs on Fe3O4 NPs including cellular uptake,
cytotoxicity, and cell activation. This toxicological assessment was performed in rat
aortic endothelial cells (RAEC) and exposures occurred under flow conditions to more
accurately depict the in vivo environment. Overall, this study strives to promote our
understanding of nanotoxicity, as well as, the development of safe nano-therapeutics
utilizing relevant exposure conditions, which more accurately portrays the in vivo
environment.
In addition to the defects in SWCNT structure as shown in Chapter three,
physiological environment also has a significant impact on the formation of the BC and
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can alter SWCNT-biomolecular interactions and subsequent cellular responses.
Individuals that suffer from underlying diseases which modify serum biomolecule
content will likely form unique BCs compared to healthy individuals. Introduction of NPs
into these individuals with high cholesterol may result in altered BC formation that
impacts NP-cellular interactions and responses. This BC that formed in high cholesterol
serum exacerbated the inflammatory response of endothelial cells following exposure
compared to normal serum BCs. This finding demonstrates how disease-induced
alterations in the physiological environment can impact NP biological response by
altering the BC.

4.2 Materials and methods

4.2.1 Isolation of Normal and Hyperlipidemic Rat Serum
Serum samples were kindly provided by Dr. Urmila Kodavanti at the US
Environmental Protection Agency. Briefly, healthy male Sprague Dawley rats (Charles
River Laboratories Inc, Raleigh NC) received water ad libitum and were fed either a
normal diet of standard (5001) Purina rat chow (Brentwood, MO) or a diet high in
fructose (60%) (TD89247, Harlan Laboratories, Madison, WI). All rats were maintained
in an isolated animal room in an Association for Assessment and Accreditation of
Laboratory Care (AALAC) approved animal facility 21 ± 1° C, 50 ± 5% relative
humidity, and 12 h light/dark cycle. Following 2 weeks on the diets animals were
necropsied and blood was collected without anticoagulant present via abdominal aortic
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puncture. Following processing of serum, samples were pooled and aliquoted to be
stored at -80°C. Serum from rats fed a normal diet (normal serum) demonstrated a
cholesterol content of 122.27 mg/dl whereas serum from rats fed a high fructose diet
(lipid serum) demonstrated a cholesterol content of 253.11 mg/dl.

The U.S. EPA

NHEERL Institutional Animal Care and Use Committee (IACUC) approved the protocol.
The animals were treated humanely and with regard for alleviation of suffering.

4.2.2 Formation and characterization of Fe3O4 Nanoparticle-Biocorona
Spherical 20 nm Fe3O4 NPs suspended in PVP at a concentration of 20 mg/ml
were purchased from Nanocomposix (San Diego, CA). BCs were formed on Fe3O4 NPs
as described in our recent publications [76], [124], [99], [125]. Fe3O4 NPs were diluted
in water to a concentration of 1 mg/ml incubated for 8 h at 10° C in distilled (DI) water
(control), 10% normal serum, or 10% lipid-rich serum. Specifically, 250 ul of Fe3O4 NP
(1 mg/ml), 650 μl of water, and 100 μl of serum were combined in a 1.5 ml tube.
Following incubation Fe3O4 NPs were then pelleted via centrifugation 14,000 rpm
(20,817 x g) 10 min and washed with PBS. Following centrifugation, the supernatant
was removed and Fe3O4 NP was resuspended with 250 μl of water to its initial
concentration of 1 mg/ml. The BC formed following incubation of Fe3O4 NPs in normal
serum is referred to as Fe3O4 NP – Normal BC whereas the BC form following
incubation in lipid-rich serum is referred to as Fe3O4 NP – Lipid BC.
For characterization, we measured the hydrodynamic size and zeta potentials
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(ZetaSizer Nano, Malvern) of uncoated Fe3O4 NPs, and Fe3O4 NPs with BCs in DI water
with Fe3O4 NPs at a concentration of 50 μg/ml (n=3/particle). Cholesterol content of the
BCs formed on the surface of Fe3O4 NPs was evaluated via a commercially available
colorimetric total cholesterol assay kit (Cell Biolabs, San Diego, CA) following
manufacturer’s instructions. Briefly, 50 μl of Fe3O4 NPs without or with BCs were
loaded into a 96 well plate in duplicate and then were treated with a cholesterol reaction
reagent that includes cholesterol esterase, cholesterol oxidase, and a colorimetric probe.
The cholesterol esterase causes the hydrolysis of cholesterol esters from the cholesterol
bound to the Fe3O4 NPs allowing for their determination.
Transmission electron microscopy images were obtained using a Hitachi H7600
microscope. For TEM studies, Fe3O4 NP – Normal BC and Fe3O4 NP – Lipid BC
samples were stained by incubating them in 0.1% OsO4 solution for 30 min. The samples
were washed with double distilled water to remove unbound OsO4 after which the
samples were drop casted on a 400 mesh Cu grid and dried overnight. Z-contrast images
were also acquired using Hitachi HD2000 microscope without staining the samples. The
high Z-contrast between Fe3O4 NPs and BC allowed us to distinguish the two phases (i.e.,
NPs and BC).
Utilizing a proteomics approach, individual protein components of the BCs were
identified similar to our previous studies evaluating the BC. Briefly, following the
addition of the BCs, Fe3O4 NPs were washed and pelleted three times with PBS (10 min
14,000 rpm / 20,817 x g). Proteins were then solubilized using 8 M urea and 10 mM
dithiothreitol (DTT) for 45 min at 60 °C.
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Fe3O4 NPs were then pelleted via

centrifugation at 15,000 x g for 10 min and the supernatant containing solubilized
proteins was collected. Protein samples were then treated with 30 mM iodoacetamide for
30 min in the dark at room temp followed by the addition of 10 mM DTT in 50 mM
ammonium bicarbonate (ABC) for 30 min at room temperature. Finally, 50 mM ABC
was used to dilute remaining urea to less than 1 M. Samples were then proteolyzed using
porcine trypsin (0.1 μg/ml) overnight at 37 °C, heated to 90 °C to deactivate trypsin, and
concentrated to dryness. Samples were then resuspended in 0.1% trifluoroacetic acid in
water, purified via Ziptip Pipette Tips (Millipore, Billerica, MA), and concentrated to
dryness. Samples were then resuspended in 0.1 % Formic Acid in DDI water and
injected into a Bruker Impact HD Q-TOF mass spectrometer (Bruker Daltonic, Billerica,
MA). The acquired data were searched using a MASCOT (ver. 2.4.1) search engine with
a peptide cutoff of 10 ppm and a minimum peptide score of 20 and a protein score of 40.
The false discovery rate for samples was < 1% and the significance threshold was p <
0.05. To determine differences in common protein components of the BCs, ratios of
individual proteins were assessed utilizing Proteinscape and Profileanalysis software
packages (Bruker Daltonic, Billerica, MA). Four samples of each BC were analyzed
individually and injected 4 separate times. Peptides to be considered for evaluation had
to be found within 5 of 8 samples with a minimum of 2 per BC type. Only peptides
determined to be statistically significant were utilized to calculate ratios and more than
one peptide had to be identified for a protein for that individual protein to be quantified.
4.2.3 Cellular uptake and cytotoxicity
Rat aortic endothelial cells (RAEC) were cultured in rat endothelial cell growth
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media (Cell Applications Inc., San Diego, CA). Cell lines were maintained in flasks
under standard conditions at 37°C and 5% CO2. For the assessment of the BC and its
role in cellular responses, all experiments were performed utilizing serum-free media as
done in our previous experiments [99], [125]. The removal of serum from media allows
for the evaluation of the intentionally formed BC without the addition of a secondary BC
within the cell culture system. The use of serum-free media limits the study of the BCs
and the cellular responses to acute time points.
To assess Fe3O4 NP Cytotoxicity RAEC cells were grown to 90% confluency in
96 well plates (Costar) and were exposed to increasing concentrations of Fe3O4 NPs (0,
2.5, 5, 10, 20, 40, 80 μg/ml) with or without BCs for 2 h and 6 h in serum-free media in a
static system. Cells were exposed in this static system due to the high number of
concentrations evaluated and to screen for overt cytotoxicity. Due to the use of serumfree media, later time points were not evaluated. The concentrations of Fe3O4 NPs
utilized were selected based on possible human exposures as well as previous in vitro
examination of Fe3O4 NPs and other NPs. Briefly, concentrations of Fe3O4 NPs were
determined based on levels used for human MRI analysis utilizing Fe3O4 NPs as a
contrast agent, which typically range from 5-10 μg/ml blood volume, considering a male
of 90 kg [126], [127]. Changes in cell viability were assessed via the 3-(4,5dimethylthiazol-2-yl)-5-(3-carboxmethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay (Promega, Madison, WI) via manufacturer’s instructions using a
spectrophotometer (BioTek Synergy HT, BioTek, Winooski, VT). No overt cytotoxicity
was identified therefore a concentration of 20 μg/ml was utilized for all subsequent
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experimentation of RAEC uptake and activation. This concentration of 20 μg/ml was also
selected due to it being within the range of a human-relevant concentration.
In order to more accurately depict the in vivo environment, RAEC uptake of
Fe3O4 NPs was assessed utilizing a Quasi Vivo system (Kirkstall, Rotherham, UK) that
pumps media over the surface of the cells. RAECs were grown on coverslips and placed
into an individual chamber. Serum-free media (control), serum-free media containing
Fe3O4 NPs – Normal BC, or serum-free media contain Fe3O4 NPs – Lipid BC at a
concentration of 20 μg/ml was loaded into the reservoir. A flow rate of 1 ml/min of fluid
was utilized during the 2 h exposure. This NP concentration and time point were select
for the evaluation of cellular uptake based on previous research examining the uptake of
other NPs by RAECs and possible human blood concentrations of Fe3O4 NPs when
utilized as an MRI contrast agent. The flow rate of 1 ml/min was estimated to result in a
shear stress of 100 x 10-3 Pa. The Quasi Vivo system as manufactured can produce a
shear stress of 2 x 10-5 Pa at a flow rate of 1 ml/min[128], however by inserting silicone
glue into the base of the chamber thereby raising the cells nearer to the inlet of media a
higher shear stress can be achieved. For comparison, a shear stress of 1.5-2.0 Pa occurs in
human arteries while the higher diameter post-capillary venules have a shear stress at 300
x 10-3 Pa [129], [130]. A shear stress of 100 x 10-3 Pa is below the necessary 200 x 10-3 –
5 Pa need to induce cell alignment and tight junctions in vitro [131]. Therefore this shear
stress utilized in this study will not induce biological responses by itself. Following
exposure, coverslips were removed from the chamber and placed into a 24 well plate.
Cells were then detached with 250 μl of trypsin and neutralized with an equal volume of
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RAEC media. Cells were then washed 3 times with PBS and differences in uptake were
determined by ICP-MS analysis of Fe content. All samples were dissolved in 6 ml of 2%
HNO3.

The Fe concentration was determined with ICP-MS (X series II, Thermo

Scientific) using an internal standard containing Li, Y and In with a detection limit of 3
ppb. Qualitative assessment of Fe3O4 NP uptake was performed by darkfield microscopy
(Cytoviva, Auburn, AL). RAECs underwent the same exposure protocol, were fixed with
2% paraformaldehyde and had their nucleuses stained with DAPI. Focusing on the
nucleus allowed for the assessment of internalized Fe3O4 NPs.
RAEC activation by Fe3O4 NPs without or with BCs was assessed utilizing a
Quasi Vivo system (Kirkstall, Rotherham, UK) at a flow rate of 1 ml/min of fluid.
RAECs were grown on coverslips and placed into an individual chamber. Serum-free
media (control), serum-free media containing Fe3O4 NPs – Normal BC, or serum-free
media contain Fe3O4 NPs – Lipid BC at a concentration of 20 μg/ml was loaded into the
reservoir and cells were exposed for 1 h. Total RNA was isolated from cells using
Direct-zol RNA MiniPrep (Zymo Research Corp., Irvine, CA) via manufacturer’s
instructions and quantified via nanodrop (Nanodrop 2000c Spectrophotometer, Thermo
Scientific).

Total RNA was reverse transcribed to cDNA using an iScript cDNA

Synthesis Kit (Bio-Rad Laboratories, Hercules, CA). A rat endothelial cell biology PCR
array was utilized to identify markers of endothelial activation following exposure to
Fe3O4 NPs without or with BCs (RT2 Profiler PCR Array Systems, Cat# PARN-015Z,
SABiosciences; Frederick MD).

This PCR array identified 84 genes related to

angiogenesis, vasoconstriction/dilation, inflammatory response, apoptosis, cell adhesion,
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coagulation and platelet activation. Plates were prepared according to manufacturer’s
instructions and using a StepOnePlue Real-Time PCR System (ABI, Foster City, CA).
Data analysis on SaBiosciences web-based PCR array expression analysis suite utilized
the ΔΔCt method with normalization to β-actin (housekeeping gene) and considering
serum-free media exposed cells as controls.
All data are presented as mean ± SEM consist of 3-6 experiments. Data were
analyzed by one-way ANOVA, with differences between groups assessed by Tukey’s
post hoc tests. All graphs and analysis were performed using GraphPad Prism 6 software
(GraphPad, San Diego, CA, USA). Statistical significance was determined when p was
found to be less than or equal to 0.05 between groups.

4.2.4 Formation and evaluation of the SWCNT-Biocoronas
BCs were formed on SWCNTs (n=6/group) using a modified Tenzer’s method, as
described in our recent publications.[76], [118], [132]

Individual SWCNTs were

suspended water at a concentration of 1mg/ml and incubated in either 10% normal or
10% hyperlipidemic serum to be mixed constantly for 8 h at 4C. Specifically, SWCNTs
following suspension were sonicated for 5 min in an inverted cup-horn sonicator at an
amplitude of 75. 250 ul of SWCNTs (1mg/ml), 650 ul of water, and 100 ul of serum
were combined in a 1.5 ml tube. Following the 8 h incubation SWCNTs were pelleted
via centrifugation 14,000 rpm (20,817 x g) 10 min and washed with PBS. This washing
process was repeated three times. Following the final centrifugation, the supernatant was
removed and SWCNTs were resuspended with 250 ul of water to their initial
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concentration of 1 mg/ml. The BC formed following incubation of SWCNTs in normal
serum is referred to as SWCNT-Normal BC whereas the BC formed the following
incubation in hyperlipidemic serum is referred to as SWCNT-Lipid BC.
We used proteomics approach to individual protein components of the BCs
similar to our previous studies evaluating the BC.[28] Briefly, following the addition of
the BCs, SWCNTs were washed and pelleted three times with PBS (10 min 14,000 rpm /
20,817 x g). Proteins were then solubilized using 8 M urea and 10 mM dithiothreitol
(DTT) for 45 min at 60 °C. SWCNTs were then pelleted via centrifugation at 15,000 x g
for 10 min and the supernatant containing solubilized proteins was collected. Protein
samples were then treated with 30 mM iodoacetamide for 30 min in the dark at room
temp followed by the addition of 10 mM DTT in 50 mM ammonium bicarbonate (ABC)
for 30 min at room temperature. Finally, 50 mM ABC was used to dilute remaining urea
to less than 1 M. Samples were then proteolyzed using porcine trypsin (0.2 ng/μl)
overnight at 37 °C, heated to 90 °C to deactivate trypsin, and concentrated to dryness.
Samples were then resuspended in 0.1% trifluoroacetic acid in water, purified via Ziptip
Pipette Tips (Millipore, Billerica, MA), and concentrated to dryness. Samples were then
resuspended in 0.1 % Formic Acid in HPLC-grade water and injected onto a nHPLC
utilizing a flow rate of 800 nL/min with a gradient of 5-50% 0.1% formic acid in
acetonitrile (ACN) over 30 min on C18 trapping (20x0.1 mm2) and analytical columns
(150x0.1 mm2). The nLC was coupled to a nano-ESI source and Impact HD Q-TOF
mass spectrometer (Bruker Daltonics, Inc., Billerica, MA). The acquired data were
searched using a MASCOT (ver. 2.4.1) search engine with a peptide cutoff of 10 ppm
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and a minimum peptide score of 20 and a protein score of 40. The false discovery rate
for samples was < 1% and the significance threshold was p < 0.05. These identified
proteins were then assessed for biological pathways SWCNTs may interfere with and
common protein characteristics by via the Gene Ontology Consortium database
(geneontology.org,) and using only mapped identifiers. To determine differences in
common protein components of the BCs, ratios of individual proteins were assessed
utilizing ProteinScape and ProfileAnalysis software packages (Bruker Daltonic, Billerica,
MA). Four samples of each BC were analyzed individually and injected 4 separate times.
Peptides to be considered for evaluation had to be found within 5 of 8 samples with a
minimum of 2 per BC type. Only peptides determined to be statistically significant were
utilized to calculate ratios and more than one peptide had to be identified for a protein for
that individual protein to be quantified. Data generated allowed for comparisons of the
BCs between SWCNTs that had undergone ball milling resulting in altered defect loads
and comparisons between the BCs that formed under the differing physiological
conditions (normal vs hyperlipidemic).
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4.3 Results and discussion
4.3.1 Case of Fe3O4

Nanoparticle

Hydrodynamic Size
(nm)

Zeta Potential
(mV)

Cholesterol
Content (μM)

Fe3O4

103.0 ± 2.3

-34.1 ± 0.6

------------

Fe3O4 – Normal BC

117.3 ± 5.5

-24.1 ± 0.4 *

7.2 ± 0.3

Fe3O4 – Lipid BC

107.4 ± 5.5

-23.0 ± 1.4 *

62.2 ± 13.1#

Table 4.3.1: Fe3O4 NP-Biocorona Characterization (n=3). * denotes statistical difference
from Fe3O4 without BC (p ≤ 0.05). # denotes statistical difference from Fe3O4 – Normal
BC (p ≤ 0.05).

Figure 4.3.1: Venn diagram representing the distribution of protein components found to
associate with 20 nm Fe3O4 NPs following incubation in 10% normal (blue) or
hyperlipidemic (red) serum.
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Following incubation of Fe3O4 NPs in 10% normal or lipid-rich serum and
formation of the biocoronas (BC), hydrodynamic size and zeta potential were assessed
(Table 4.3.1). Formation of either BC slightly increased the hydrodynamic size of the
Fe3O4 NPs (Table 4.3.1). However, the formation of both the normal BC and lipid BC
on Fe3O4 NP resulted in a significant decrease in zeta potential (Table 4.3.1).
Variations in the cholesterol content and protein components of the BCs formed
on Fe3O4 NPs in the differing physiological environments were evaluated. Assessment of
the cholesterol content of each BC demonstrated cholesterol as a component of both BC.
As expected, the lipid BC had a greater amount of cholesterol associated with it
compared to the normal BC (Table 4.3.1). Label-free proteomics was utilized to evaluate
differences in protein components of the BCs. The BCs on Fe3O4 NPs incubated in either
normal or lipid-rich serum were found to consist of 103 or 121 individual proteins
respectively (Fig. 4.3.1). In common between the two BCs were 92 proteins including
complement C3, prothrombin, serum albumin, serotransferrin, alpha-2-HS glycoprotein,
apolipoprotein A-II, apolipoprotein E, and apolipoprotein C-I (Fig. 4.3.1). Fe3O4 NP with
a normal serum BC was determined to bind 11 unique proteins when compared to Fe3O4
NP with a lipid-rich BC. Fe3O4 NP with a lipid-rich BC was found to bind 29 unique
proteins when compared to Fe3O4 NP with a normal BC. A complete list of all proteins
found to associate with Fe3O4 NP following incubation in the different physiological
environments can be found in ref [28].
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Figure 4.3.2. False-colored transmission electron micrographs for (a) Fe3O4 NPs, (b)
Fe3O4-Normal BC, and (c) Fe3O4-Lipid BC. Biocorona is shown in blue (b) and green
colors (c). The Fe3O4 NPs were observed to be embedded in BC. The black arrows in (c)
show liposome structures formed in Fe3O4-Lipid BC.

As shown in Fig. 4.3.2, bare Fe3O4 NPs were found to have a mean size of ~30
nm. This is significantly smaller than the hydrodynamic size (>100 nm) suggesting that
there may be some agglomeration of Fe3O4 NPs in solution. Additionally, TEM images
showed that the Fe3O4 NPs are not completely spherical. We found that both Fe3O4Normal BC and Fe3O4- Lipid BC contained Fe3O4 NPs embedded BC (Fig. 4.3.2 B and
C). Interestingly, we also found the presence some liposomes in Fe3O4-Lipid BC, which
were confirmed by OsO4 staining and Z-contrast studies.
To determine possible differences in cytotoxicity due to the addition of the BCs,
rat aortic endothelial cells (RAECs) were exposed to Fe3O4 NPs without or with BCs at
concentrations of 2.5, 5, 10, 20, 40, or 80 μg/ml for 2 h or 6 h and examined for
differences in viability. This initial assessment of cytotoxicity was performed in a static
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cell culture system due to the number of concentrations examined. Due to the removal of
serum from the cell culture media, only acute time points were evaluated. None of the
concentrations utilized were found to induce significant cytotoxicity. Furthermore, the
addition of the BCs was not found to alter cytotoxicity. Based on these data, previous
work evaluating NP toxicity in RAEC, and relevant human concentrations a
concentration of 20 μg/ml was utilized for all experimentation investigating diseaseinduced BC toxicity [126], [127]

Figure 4.3.3:

Measurement of 20 nm Fe3O4 NP uptake by ICP-MS and darkfield

microscopy. Rat aortic endothelial cells (RAEC) were exposed to serum-free media
(control), Fe3O4 NPs without a biocorona (BC), or Fe3O4 NPs with either a normal serum
or lipid serum BC. Cells were exposed to a concentration of 20 μg/ml for 2 h under flow
conditions of 1 ml/min. A) Following exposure, cells were assessed by ICP-MS for
Fe3O4 NP uptake. Values are expressed as mean ± SEM (n=3/group). * Indicates
significant difference from controls (p < 0.05). B) Alterations in RAEC uptake of Fe3O4
NPs due to the addition of BCs was qualitatively evaluated via darkfield microscopy.
Fe3O4 NPs without a BC are identified with red arrows, Fe3O4 NP-normal BC with blue
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arrows, and Fe3O4 NP-lipid BC with green arrows.
BC-induced alterations in RAEC uptake were evaluated by ICP-MS and darkfield
microscopy (Figure 4). RAECs were exposed to 20 μg/ml of Fe3O4 NPs without or with
BCs for 2 h under a flow rate of 1 ml/min. RAECs were found to readily internalize
Fe3O4 NPs without a BC, however, addition of both BCs resulted in reduced uptake as
evaluated by ICP-MS (Fig. 4.3.3A). These results were qualitatively confirmed via
darkfield microscopy (Fig. 4.3.3B). Fe3O4 NPs without a BC were internalized (red
arrows) to a greater degree than Fe3O4 NPs with a normal BC (blue arrows) or Fe3O4 NPs
with a lipid BC (green arrows).
To determine differences in Fe3O4 NP-induced RAEC activation due to the
addition of the BCs, mRNA gene expression was examined. RAECs were exposed for 1
h to 20 μg/ml of Fe3O4 NPs without or with BCs under a flow rate of 1 ml/min. A PCR
array specific for rat endothelial cell biology was utilized which evaluated mRNA
expression changes in 85 genes related to a variety of processes.

These processes

included angiogenesis, vasoconstriction/dilation, inflammatory response, apoptosis, cell
adhesion, coagulation and platelet activation. In summary, RAECs exposed to Fe3O4
NPs without a BC demonstrated a significant (p ≤ 0.05) upregulation of 4 genes and
downregulation of 10, while cells exposed to Fe3O4 NPs with a normal BC had 7 genes
upregulated and 18 down-regulated and those exposed to Fe3O4 NPs with a lipid BC had
10 genes upregulated and 8 down-regulated. Exposure to all Fe3O4 NPs (without and
with BCs) significantly altered the expression of a subset of genes in common including
the upregulation of Cx3cl1, Cxcl1, Selp, and VCAM1 and the downregulation of Ednra,
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Hif1a, and Sod1. Inflammatory genes such as IL-6, Cxcl1, Cxcl2, and TNF were induced
to a greater degree upon RAEC exposure to Fe3O4 NPs with BCs compared to the
absence of a BC. The induction of these inflammatory genes was greatest in RAECs
exposed to Fe3O4 NPs with a lipid BC. Verification of VCAM-1 mRNA expression seen
in the PCR array through real-time PCR demonstrated similar gene induction. Additional
controls were added to this experiment to ensure that changes seen in mRNA expression
were not related to carry over of free serum proteins (proteins not associated with Fe3O4
NP BCs).

These control groups demonstrated no changes in VCAM-1 mRNA

expression. To further assess activation of RAEC by Fe3O4 NPs without or with BCs, cell
surface expression of VCAM-1 was evaluated by immunofluorescence (Fig. 4.3.4). Cells
again were exposed under flow conditions of 1 ml/min to Fe3O4 NPs without or with BCs
(20 μg/ml) for 1 h and stained for VCAM-1 expression. Fe3O4 NPs without a BC and
Fe3O4 NPs with a normal BC did not demonstrate differences in VCAM-1 expression
compared to controls (Fig.4.3.4). Exposure to Fe3O4 NPs with a lipid BC, however, did
demonstrate increased cell surface expression of VCAM-1. This alteration in surface
VCAM-1 expression verified results examining mRNA expression.
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Figure 4.3.4: Assessment of Fe3O4 NP-BC alterations in cell surface expression of
VCAM-1 by immunofluorescent staining. Rat aortic endothelial cells (RAEC) were
exposed to serum-free media (control), Fe3O4 NPs without a BC or Fe3O4 NPs with either
a normal serum or lipid serum BC. Cells were exposed to a concentration of 20 μg/ml for
1 h under flow conditions of 1 ml/min. Cells were then immunofluorescently stained
with DAPI to identify the nucleus (Blue) and with a VCAM-1 antibody to identify
endothelial cell surface expression of VCAM-1 (Green).
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4.3.2 Case of SWCNTs
A substantial portion of our population exists with an underlying health condition.
These underlying conditions often modify the biomolecular content of the individual’s
serum. Since the formation of the biocorona is dependent on both the physicochemical
properties of the engineered nanomaterial as well as the physiological environment it
likely that underlying disease states will result in unique biocorona formation.21 One
highly prevalent and growing disease state is hyperlipidemia or high cholesterol. Previous
evaluation has demonstrated that incubation of iron oxide nanoparticles in hyperlipidemic
serum results in the formation of unique biocoronas compared to incubation in normal
serum.21 Further, the addition of the hyperlipidemic biocorona was determined to induce
greater inflammatory responses in endothelial cells suggesting increased toxicity of
nanoparticles in individuals with hyperlipidemia. In our current study, we evaluated the
biocorona that forms on SWCNTs that have been either untreated or ball milled in both
normal and hyperlipidemic serum. In order to understand nanoparticle-biomolecular
interaction, it is necessary to examine common disease states.
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Figure 4.3.5: Venn diagrams representing the number of proteins found to associate with
SWCNTs due to incubation in either normal or hyperlipidemic serum.

A proteomic comparison of the protein components of the biocorona that forms
on SWCNTs following incubation in either normal or hyperlipidemic serum
demonstrated that the majority of proteins were in common (Fig. 4.3.5). These common
proteins included apolipoprotein AI, C reactive protein, fibronectin, kininogen-1,
plasminogen, and others. Unique to the normal serum biocorona were proteins alpha-1
antitrypsin 1-4, hemoglobin subunit A, and others.

Unique to the hyperlipidemic

biocorona were hepcidin, extracellular matrix protein 1, antithrombin-III, and others.
Interestingly, as ball milling time was increased, fewer proteins were shared between the
normal and hyperlipidemic serum biocoronas. This corresponded with a trend of more
unique proteins in the normal serum biocorona compared to the hyperlipidemic serum
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biocorona as ball milling time increased (Fig. 4.3.5). Further, the hyperlipidemic serum
biocorona demonstrated less unique proteins compared to the normal serum biocorona as
ball milling time increased. It is likely that due to the amount of cholesterol present in
the hyperlipidemic serum that cholesterol outcompeted proteins for binding sites on the
SWCNTs. This competition may explain the decreases in common proteins between the
normal and hyperlipidemic biocoronas as increased ball milling time enhanced the
surface area of SWCNTs resulting in more cholesterol association. To date, few studies
have evaluated the lipid content of the biocorona that forms on engineered nanomaterials.
Future research is needed regarding the association of lipids on engineered nanomaterials
in physiological environments.[133] It is likely that they not only modify the association
of other biomolecules but also nanomaterial-cellular interactions.
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Figure 4.3.6: Differences in relative abundance of specific proteins (Transthyretin,
Clusterin, Complement C1q Subcomponent Subunit B, and Alpha-2-HS-Glycoprotein)
found to associate with SWCNTs in hyperlipidemic serum due to ball milling time. For
normal serum refer Fig. 3.3.11. All ratios are As Prepared SWCNTs : Ball Milled
SWCNTs.

Although a majority of proteins were shared between the normal and
hyperlipidemic biocoronas on SWCNTs differences were determined regarding their
abundance (Fig. 4.3.6). Many proteins such as immunoglobulin kappa V-III,
apolipoproteins E, C-I, A-II, and A-I, and complement C1q subcomponent subunit B,
complement

C1s-A

subcomponent,

complement

C3

and

complement

C1r-A

subcomponent were found to be enriched within the hyperlipidemic biocorona on As
Prepared SWCNTs. As Prepared SWCNTs in hyperlipidemic serum associated greater
amounts of apolipoproteins and complement factors likely due to their increased
abundance in hyperlipidemic serum. Many of the shared proteins found to be decreased
in the hyperlipidemic compared to the normal biocorona appear to be high abundant
serum proteins. This suggests that the increased lipid content maybe competing with
them for binding sites on the SWCNTs. Further, this data overall demonstrates that the
biocorona is not only different due to structural modification induced by ball milling but
also due to the physiological environment. Although they share numerous proteins the
abundance of these proteins are not uniform. These variations in abundance further
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demonstrate altered biomolecular interactions, distinct biocorona formation, and the
possibility for modified cellular responses.
Again, gene ontology was used to evaluate proteins related to specific biological
pathways and classes of proteins that associated with SWCNTs. For this comparison of
biological pathways and protein classes, proteins that were found to bind in common
between normal and hyperlipidemic serums regardless of ball milling were utilized.
Further only proteins that were unique and never shared between samples were used to
explain pathways and classes that were unique to serum environment. Assessment of
commonly associated proteins demonstrated that proteins associated with the biological
pathways of blood coagulation, integrin signaling, inflammation-mediated by chemokine
and cytokine signaling, vitamin D metabolism, plasminogen activating cascade and
others. Assessment of the unique protein components of the biocoronas primarily added
proteins to the identified common pathways. The hyperlipidemic biocorona on SWCNTs
however uniquely associated glyceraldehyde-3-phosphate dehydrogenase which is
involved in the biological pathway of glycolysis. Although most of the proteins that
associated with SWCNTs in normal and hyperlipidemic serums were associated with the
same biological pathways it is interesting that there were unique proteins that bound.
Therefore, classes of the proteins that associated with SWCNTs were evaluated. Proteins
that bound in common were found to have been from classes of proteins involved in
enzyme modulation, transfer/carrier, defense/immunity, signaling, transporter, receptor
and others. Uniquely associated proteins primarily were from similar classes to the ones
that were shared of proteins that were shared. The hyperlipidemic biocorona, however,
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was found to associate with single proteins from the classes of transcription factor and
nucleic acid binding (transcription factor HIVEP2), and isomerase (major urinary
protein-1). Again, this assessment demonstrated that although proteins that bound to the
SWCNTs were from similar protein classes specific proteins that bound were unique.

4.4 Conclusions

In summary, our study demonstrates the impact of underlying disease states on
the formation of the BC on Fe3O4 NPs and its implications for the safe development of
NPs for biomedical applications. Although numerous studies have demonstrated that the
physicochemical properties of NPs result in differential BC formation, few have
examined the role of the physiological environment in terms of variations due to
underlying disease states. The addition of the lipid BC was determined to influence
cellular uptake and activation, thereby having consequences for the safe utilization of
NPs.

In the current study we investigated a common human disease state,

hyperlipidemia, however, numerous other conditions are known to alter physiological
environments, which may influence the formation of the NP-BC and toxicity thereby
requiring additional investigation. There are also many other biological fluids other than
serum that NPs may come into contact with due to their routes of exposure such as
bronchoalveolar fluid, gastrointestinal fluid, and others.

In order for the safe and

effective use of NPs for biomedical applications, it is necessary to evaluate the formation
of the BC in different environments and assess its impact on NP function and toxicity.
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A common disease-induced alteration in the serum environment can also result in
modified biocorona formation. Further, these disease-related changes in the physiological
environment demonstrate differences due to SWCNTs ball milling when compared to
normal conditions. Toxicological experimentation of exposures to SWCNTs often
focuses on end product exposure and healthy/normal physiological conditions. However,
often nanomaterials are modified through processes such as ball milling which may
influence nanomaterial-biomolecule interactions. In order to protect the population from
unintended adverse responses, it is necessary to understand how these modifications in
the nanomaterial’s surface and the biological environment can alter nanomaterialbiomolecule interactions which may govern biological responses such as toxicity,
biodistribution, and clearance.
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CHAPTER FIVE
CHARGE TRANSFER INTERACTIONS OF NANOMATERIALS WITH
BIOMOLECULES
Raghavendra, Achyut J., et al. "Charge-transfer interactions induce surface dependent
conformational changes in apolipoprotein biocorona." Biointerphases 12.2 (2017):
02D402. Reproduced in part with permission of Biointerfaces.
Mallineni, Sai Sunil Kumar, et al. "Biomolecular Interactions and Biological Responses
of Emerging Two-Dimensional Materials and Aromatic Amino Acid Complexes." ACS
applied materials & interfaces 8.26 (2016): 16604-16611. Produced in part with
permission of American Chemical Society.

5.1 Introduction

There is an immediate need to focus our attention on emerging two-dimensional
(2D) layered materials such as graphene, graphene oxide (GO), and BN. Many medical
applications are envisaged for 2D materials in multiple areas including cancer drug
delivery, clot-resistant coatings for biomedical implants, and biomedical imaging[134]–
[139]. In the physiological environment, the high surface area of 2D materials, compared
to 0D and 1D materials[140], opens new possibilities for relatively stronger non-covalent
biological interactions through efficient  stacking and hydrogen bonding with
biomolecules present in the biocorona. A critical first step in understanding the formation
and subsequent influence of biocorona is to study how 2D materials (essentially
equivalent to surfaces) interact with amino acids. The aromatic rings in certain amino
acids (e.g., tryptophan, tyrosine, and phenylalanine) could be expected to interact
strongly with 2D materials, and thereby adversely influence the transport and uptake of
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essential amino acids critical for protein synthesis. It is known that deficiencies in even a
single essential amino acid (e.g., tryptophan) could alter immunity and increase disease
susceptibility.[141] Furthermore, it has been suggested that the adsorption characteristics
of a diverse set of small molecules such as amino acids could be used to develop
quantitative-structure activity relationships or QSARs for predicting biocoronal
fingerprint of ENMs[142]. Therefore, it is important to understand the interactions
between 2D ENMs and amino acids in order to guide the emerging medical applications
and aid in the development of new toxicity and QSAR models. To this end, we used
micro-Raman and photoluminescence spectroscopy combined with electrochemical
characterization to study the electronic interactions between three aromatic amino acids
(tryptophan, tyrosine, and phenylalanine) and three different types of 2D materials
(graphene, GO, and BN). As demonstrated in this study, the interactions between
biomolecules and 2D materials significantly perturb the ENM electronic structure, which
could be elucidated through changes in the Raman spectra of 2D materials and quantified
using cyclic voltammetry. The rationale for choosing this particular set of 2D materials
(viz., graphene, GO, and BN) is multi-fold: i) the widely used graphene and GO exhibit
strong non-covalent interactions (stacking and hydrogen bonding) with aromatic
molecules due to delocalized electrons or the presence of functional groups, ii) although
graphene and BN are structural analogues, they exhibit differences in  -electron cloud
distribution. The  -electron cloud is uniformly delocalized in graphene while it is
centered near N atoms in BN. Such differences facilitate the investigation of different
orientations in stacking, and iii) while graphene and BN are hydrophobic, GO is
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hydrophilic and has been proposed to exhibit possible hydrogen bonding with
biomolecules leading to interactions distinct from graphene and BN[143]. Our results
show that tyrosine and tryptophan strongly interact with 2D materials, unlike
phenylalanine. More importantly, we found evidence for charge transfer between
aromatic acids and graphene & GO. Such charge transfer reactions[144] are known to be
important for predicting oxidative stress potential of ENMs [145] and developing
biomolecular sensors.
Although many physicochemical characteristics of ENMs have been reported to
influence ENM-BC, it is not yet clear what combination of these properties could be used
to predict ENM-BC formation and evolution [25], [146]. The composition of ENM-BC is
known to strongly depend on ENM size and surface charge [6], [9], [27], [58], [119],
[124], [147]–[152]. Larger ENMs exhibit a preferential adsorption of higher molecular
weight proteins whereas lower molecular weight proteins accumulate more on the surface
of smaller ENMs. On the other hand, surface charge is expected to be a key factor in
determining protein structural changes [6], [9], [25], [119], [146], [151], [153]. The
interactions between ENM surface and proteins could disrupt the structural integrity of
proteins in ENM-BC and impact their function or elicit adverse immune responses. The
surface coatings or functional groups are physically and chemically more active relative
to the core of ENM. For instance, citrate groups adsorbed on the surface of Ag
nanoparticles (AgNPs) are negatively charged and provide electrostatic repulsion needed
to prevent AgNP agglomeration. Any oppositely charged biomolecules (compared to
surface functional groups on ENM) experience a natural electrostatic attraction to adsorb
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on ENM surface. Proteins with a stronger affinity to the ENM core can quickly displace
the initially present functional groups and be irreversibly immobilized on ENM surface
by partial or complete denaturation [25], [119], [154]. A combination of many factors
including van der Waals forces, hydrogen bridges, charge transfer and other hydrophobic
interactions are known to drive protein denaturation [155], [156], [11], [157]. Such
factors naturally depend upon ENM physicochemical properties. It is imperative to
deconvolute the influence of different physicochemical properties (e.g., surface charge
and size) and understand how they differ from each other in influencing protein
adsorption and denaturation in ENM-BC.
Here, we experimentally investigated the influence of AgNP surface charges on
adsorption and denaturation of apolipoprotein A-I (ApoA-I). Considering that ApoA-I is
one of the most abundant proteins in AgNP-BC irrespective of AgNP size [124], its
adsorption on AgNPs with different surface coatings could provide new insights into the
role of surface charges in ENM-BC. ApoA-I is the major protein component of highdensity lipoprotein (HDL). It adopts a shape similar to a horseshoe of dimensions
12.5x8x4 nm with high α-helix content [53], [158]–[161]. The helices in ApoA-I are
predicted to be amphipathic, with the hydrophobic (/hydrophilic) face mediating lipid
(/aqueous) interactions. The thermodynamic drive to minimize the aqueous exposure of
the hydrophobic residues is one of the major factors in ApoA-I adsorption on AgNPs
[162], [163]. Our light scattering and surface charge studies on 100 nm AgNPs (with four
different functional groups) revealed that the binding of ApoA-I on AgNPs is sensitive to
their surface charge and functionality. While ApoA-I exhibited a strong affinity for both
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positively and negatively charged AgNPs, its secondary structure exhibited more
pronounced changes for two surface functionalities viz., lipoic acid and branched
polyethyleneimine (bPEI). In this article, we explain the observed secondary structural
changes in terms of the electronic charge transfer, gleaned from electrochemical cyclic
voltammetry experiments, between ApoA-I and functionalized AgNPs. Lastly, the
displacement of positively charged bPEI by ApoA-I and the structural changes of ApoA-I
on AgNP-lipoic acid were found to induce a significant increase in their ability to
generate reactive oxygen species (ROS). Our results provide new insights into the role of
AgNPs surface charge in ENM-BC formation and its influence on bioresponse.

5.2 Materials and methods

Graphene was synthesized using chemical exfoliation technique. Bulk graphite
(∼1 g) was suspended in 100 mL of N-methyl-2-pyrrolidinone (NMP) and sonicated
using 1/8” tip sonicator (Branson 250) at 100 W for 2 h. After sonication, the suspension
was centrifuged at 3000 rpm for 30 mins, and the supernatant was filtered through 0.45
μm nylon filter and re-suspended in 100 mL of fresh NMP. This fresh solution was
sonicated again for 6 h and centrifuged at 1500 rpm for 1 hr. The supernatant was then
vacuum filtered using a 0.45 μm nylon filter. The filtered powder was washed several
times using deionized water to remove residual NMP and air-dried to obtain exfoliated
graphene samples. GO was synthesized using the standard Hummer’s method described
elsewhere[164]. BN powder was obtained from Graphene Supermarket (SKU: BN-
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100G). It should be noted that our infrared spectroscopy studies showed that GO
contained several functional groups including hydroxyl, carboxyl, and epoxide
functionalities[164]. All pure amino acids were purchased from Sigma-Aldrich. For
studying the interactions with amino acids, 100 g of ENMs (graphene, GO, and BN)
were incubated for 12 hrs in 1 mL solution of amino acids. After incubation, the samples
were centrifuged at 13,000 rpm and the supernatant was removed. The samples were
washed thrice to remove any amino acids not adsorbed on ENMs and were finally
suspended in DI water. For transmission electron microscopy (TEM), the samples were
suspended on a 400-mesh Cu grid and the TEM images were acquired using Hitachi H7600 microscope. Micro-Raman spectroscopy was performed using 514.5 nm Ar+ ion
excitation coupled to a Renishaw micro-inVia spectrometer equipped with a 50x
objective and Peltier-cooled CCD. For Raman measurements, the samples were drop
casted on a microscope slide and were gently air-dried before collecting the Raman
spectrum. Photoluminescence measurements were obtained using a Horiba-Jobin Yvon
nanolog spectrometer equipped with a liquid-nitrogen cooled CCD.
An aqueous solution of AgNPs (100nm, NanoXact, Nanocomposix) with citrate,
polyvinylpyrrolidone (PVP), branched polyethyleneimine (bPEI) and lipoic acid as
capping agents were purchased. ApoA-I from human plasma (MW = 28.3KDa) was
purchased from Sigma-Aldrich. Different ApoA-I concentrations (0-4 g/L) were
considered with AgNPs (50 μM) to study hydrodynamic size and zeta potential using
Zetasizer Nano ZS90 (Malvern Instruments). For transmission electron microscopy
(TEM) characterization of the corona formation, AgNPs with ApoA-I biocorona were
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stained with 0.1% osmium tetroxide (OsO4) by incubating for 30 minutes. These samples
were then drop casted on 400 mesh Cu grid and TEM images were acquired using a
Hitachi H-7600 microscope.
Electrochemical studies were performed using a Gamry reference 3000
electrochemical system. Cyclic voltammetry (CV) measurements were obtained in a
three-electrode setup with Ag/AgCl as the reference electrode, platinum wire as the
auxiliary/counter electrode. GO, and boron nitride samples were drop casted on a glassy
carbon electrode (diameter: 3 mm) and air dried for 12 hours. ENMs adsorbed on the
glassy carbon were used as the working electrode with a high purity Pt counter electrode.
Stock solutions containing tyrosine, tryptophan, and phenylalanine with varying
concentrations were prepared in 0.05M PBS solution (electrolyte). For other study,
AgNPs formed the working electrode. We used ApoA-I solution as the electrolyte to
study charge transfer. It should be noted that we used concentration ranges based on the
physiological levels of ApoA-I (~1-1.3 g/L) for electrochemical studies to avoid high
current values that could result in artifacts in charge transfer measurements.
Circular

Dichroism

(CD)

measurements

were

performed

using

Jasco

spectropolarimeter (J-810) to analyze secondary structures of ApoA-I after the biocorona
formation on AgNPs. Samples were prepared for CD analysis with suspensions of
AgNPs and ApoA-I corresponding to the molar ratio of 1:600 and incubated at 40 oC for
8h. The CD spectra were measured at room temperature with a wavelength range from
200-300nm for all the samples at a scan speed of 50nm/min. Background correction was
applied with pure AgNP suspension.
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Reactive oxygen species (ROS) were evaluated using dichlorofluorescein (DCF)
assay via flow cytometry (by counting 10000 cells per sample). Macrophages were
grown to 90% confluence and exposed to 30 μg/mL of AgNPs for 1h. All the
measurements were performed in triplicates.

5.3 Results & dicussion
5.3.1 Two-dimensional nanomaterials with aromatic amino acids
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Figure 5.3.1: Representative transmission electron microscope images for (a) graphene,
(b) graphene oxide, and (c) BN. (d) Raman spectra for as-prepared graphene (red),
graphene oxide (green) and boron nitride (blue). The D-band (~1350 cm-1) and the Gband (~1590 cm-1) for graphene oxide exhibit significant broadening due to the presence
of defects. Graphene (G-band ~1585 cm-1) and BN (~1366 cm-1) exhibit sharp Raman
features indicative of good crystallinity.

As shown in Fig. 5.3.1d, graphene and GO exhibited disorder (D-band) and
graphitic (G-band) bands ~1350 cm-1 and 1581 cm-1 (~1598 cm-1 for GO) respectively.
The presence of defects in GO, induced during harsh chemical oxidation process in
Hummer’s method, resulted in a highly intense D-band and a significant broadening of
the G-band relative to graphene. While graphene samples showed a two-peaked 2D-band
~2700-50 cm-1 (see Fig. 5.2.1d inset) suggesting it to be few-layered (~5-6 layers), the
2D band in GO was suppressed due to oxidation. BN sheets exhibited a strong peak
~1366 cm-1 in their Raman indicating excellent crystallinity similar to graphene.
Previously, many theoretical studies[143], [165], [166] investigated the
interactions of aromatic amino acids with carbon-based ENMs such as carbon nanotubes
(CNTs), graphene, and GO. These studies observed that the aromatic rings of amino acids
prefer

to

stack

on

CNTs

and

graphene

sheets

due

to

the

presence

of

interactions[143], [165]. In contrast, it was predicted that GO interacts with
biomolecules (e.g., proteins, amino acids, nucleobases) through hydrogen-bonding
interactions[143]. To experimentally validate such predictions, we characterized the
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amino acid adsorption on different ENMs using isotherms obtained through
photoluminescence (PL) studies (Fig. 5.3.2). It is well known that aromatic amino acids
such as tryptophan, tyrosine, and phenylalanine exhibit strong PL when excited by ultraviolet light[144]. As discussed in the experimental section, we incubated ENMs with
different concentration of amino acids (within their physiological concentration range 070 m/L) and obtained the isotherms by measuring the PL arising from residual amino
acids on ENMs after three rounds of washing. Although it is possible to fit the observed
isotherms to Langmuir-like models, we did not derive any quantitative conclusions
because many assumptions for Langmuir isotherms are invalid in our case (e.g., the
irreversibility of adsorption)[167] [58]. Furthermore, the quenching of aromatic amino
acid PL when interacting with ENMs could lead to incorrect quantitative results.
Nonetheless, PL data could be used to glean useful qualitative information regarding the
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relative affinity among 2D materials and the orientation and stacking of amino acids.
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Figure 5.3.2: Adsorption isotherms for (a) tyrosine, (b) tryptophan, and (c) phenylalanine
on graphene, BN, and graphene oxide. Graphene oxide showed significantly higher
adsorption for tyrosine and tryptophan, possibly due to the formation of hydrogen bonds,
compared to graphene and BN (which exhibit interactions with amino acids).
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However, phenylalanine showed similar adsorption on all 2D materials that were
relatively independent of concentration.

Figure 5.3.3: (a) A graphene sheet containing p-electrons can be viewed as a quadrupole
(as depicted by green lobes in the lower panel) with a negative charge above and below
the sheet and a positive charge around the edges. Similarly, the aromatic ring (shown in
red) in tyrosine, tryptophan, and phenylalanine could be viewed as quadrupoles with
charge distribution similar to graphene. Amino acids (e.g., tyrosine shown above
graphene sheet) exhibit either edge-to-face or off-centered (b) stacking due to
quadrupole-mediated p-p interactions. (c) BN exhibits positive charge (shown in purple)
above and below the sheet due to the presence of N atoms that pull the electrons away
from the center. Accordingly, the amino acids may prefer face-centered stacking, unlike
graphene.
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Tyrosine exhibited similar adsorption trends for graphene and BN unlike GO
(Fig. 5.3.2a). As predicted from density functional theory[143], such contrasting
isotherms are expected due to the formation of hydrogen bonds (H-bonds) in the case of
GO. Interestingly, the adsorption curves for graphene and BN were similar although the
-electron cloud is uniformly delocalized in graphene while it is centered near N atoms in
BN. The delocalized -electron cloud in graphene induces a quadrupole moment with a
partial negative (/positive) charge above and below (/in-plane) the sheet (see the lower
panels in Fig. 5.3.3a and b). Tyrosine also exhibits a similar quadrupole with negative
charges above and below the aromatic ring. Thus, it may be expected that tyrosine prefers
perpendicular edge-to-face interactions or off-centered parallel stacking in lieu of facecentered parallel stacking (Fig. 5.3.3a and b). On the other hand, in case of BN, the
scenario is different because N is a relatively strong electron-withdrawing group that
polarizes the -electron density away from the core, and thereby reverses the direction of
the overall quadrupole moment (compared to graphene) by inducing a central area of
relative electron deficiency and localization of -electrons around N atoms (lower panel
in Fig. 5.3.3c). Accordingly, tyrosine may prefer face-centered stacking on BN surface
(Fig. 5.3.3c). The edge-to-face orientation in the graphene-tyrosine complex (Fig. 5.3.3a)
involves less active area of interaction and thus should allow more tyrosine molecules to
stack on graphene as opposed to off-centered stacking. Nonetheless, the adsorption
isotherms for graphene and BN (which favors only face-centered stacking for tyrosine)
are similar suggesting that the edge-to-face interactions in graphene could be possibly
ruled out. In case of GO, as observed in theoretical calculations[143], the hydroxyl group
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of the phenolic ring in tyrosine may form H-bonds with the hydroxyl groups on GO
leading to higher adsorption. Returning to Fig. 5.3.2a, we found that the adsorption on
GO saturated abruptly beyond 15 M/L for tyrosine possibly due to the saturation of
limited hydroxyl groups on the surface of GO. Furthermore, the formation of H-bonds,
which necessitates a close proximity between both hydroxyl groups (one from GO and
another from tyrosine), may also prevent multilayer adsorption in GO.
Interestingly, tryptophan exhibited a monotonically increasing trend for
adsorption on GO unlike tyrosine (Fig. 5.3.2b). The hydroxyl groups of GO are predicted
to form H-bonds with indole ring hydrogen in tryptophan[143]. In addition to the
H-bonds, tryptophan may exhibit relatively stronger - interactions with GO due to the
presence of extended -cloud in the indole ring. The adsorption of tryptophan on
graphene and BN was similar to tyrosine and could be entirely attributed to - stacking
arising from interactions of quadrupoles induced by -electron cloud (off-centered
stacking for graphene and face-centered for BN similar to the case of tyrosine).
-3

6x10

Tyrosine

-0.4

GO
BN
Gr

-0.6

-0.8
-1.0

20

0
-3

2

0

-0.2

x10

2

Charge Density (C/m )

4

Current (A)

0.0

mg/ml
0
0.42
0.75
1
1.2
1.36
Gr/Tryptophan
Scan rate: 20 mV/s

-20

-1.2
-40

-1.4
-0.2

0.0

0.2

0.4

0.6

0.8

1.0

0.0

0.0

1.2

0.2

0.4

0.2

Voltage (V)

0.8

1.0

1.2

1.4

1.4

2

Charge Density (C/m )

0.0

2

Charge Density (C/m )

0.2

0.6

0.4
0.6
0.8
1.0
1.2
Concentration (mg/ml)

0.0

Tryptophan
-0.2

GO
BN
Gr

0.20
0.15

-0.4

0.10
0.05

0.1

-0.5
0.0

-0.1

-1.0

-0.2

Phenylalanine
GO
BN
Gr

0.00

-0.6

-1.5

-0.05
0.0

0.0

0.2

0.4

0.2

0.6

0.8

1.0

1.2

-0.3
0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.4

0.4
0.6
0.8
1.0
Concentration (mg/ml)

1.2

0.0

1.4

94

0.2

0.4
0.6
0.8
1.0
Concentration (mg/ml)

1.2

1.4

Figure 5.3.4: (a) Cyclic voltammetry loops for graphene and tryptophan show the
appearance of a new peak ~0.6-0.8 V indicating irreversible charge transfer. (b-d) Charge
density isotherms derived from their corresponding CV loops for different 2D materials
and amino acid combinations. Insets shows zoomed in view of the plot of charge density
vs concentration for Gr and BN.

There was no significant difference in the adsorption of phenylalanine on
graphene, BN, and GO. This result is not surprising because the structures of tyrosine and
phenylalanine differ only by the presence of an extra hydroxyl group. The lack of
hydroxyl group in phenylalanine (unlike tyrosine) precludes the possibility of H-bonds
and thereby results in a lower affinity for GO. The qualitative conclusions, based on PL
data, were further confirmed using cyclic voltammetry studies discussed later in Fig.
5.3.4.
While the PL studies provide insights into physical adsorption and affinity
through - interactions, the nature of chemical bonding can be understood through
perturbations in electronic structure. We used cyclic voltammetry and micro-Raman
spectroscopy to understand the influence of amino acid adsorption on the electronic
structure of ENMs. We performed cyclic voltammetry (CV) measurements with ENMs
as a working electrode in amino acid electrolyte solution (Fig. 5.3.4). In CV
characterization, the application of gate voltage on the working electrode (i.e., ENMs in
our case) modulates its electronic energy levels, which when in the vicinity of energy
levels of the amino acids (present in the electrolyte) can result in a charge transfer. For
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quantifying the electrochemical charge transfer, we first obtained a base CV curve with
0.05 M PBS electrolyte solution containing no amino acids (see Fig. 5.3.4a).
Subsequently, amino acids aliquots of varying concentrations were introduced into the
electrochemical cell and scan rate normalized CV loops were obtained for each
concentration. The total amount of charge-transferred was obtained by integrating the
area enclosed by the CV curves and subtracting the base area (from the CV curve in
0.05M PBS electrolyte solution). As shown in Fig. 5.3.4b-d, we found that the chargetransfer isotherms for all ENMs and amino acid combinations showed clear trends as a
function of concentration.
In a typical CV plot, a peak in current (in a current vs. voltage plot such as the one
shown in Fig. 5.3.4a) or changes in the CV loop area indicate the presence of charge
transfer between the electrolyte (i.e., amino acid in PBS solution in our case) and the
working electrode (i.e., ENMs). The changes in CV loop area could occur due to two
reasons: i) chemisorption or binding of amino acids with ENMs results in an irreversible
reaction, which appears as a peak in the CV loop (e.g., graphene/tryptophan in Fig.
5.3.4a) and thereby changes the enclosed area, and ii) physisorption, which decreases the
available surface area of ENMs for ion adsorption leading to a decrease in the total loop
area.
The charge density isotherms (Figs. 5.3.4b-d), obtained from the CV curves,
show the combined effects of both physi- and chemisorption. We observed that GO
exhibited the largest changes in charge density suggesting the strong interaction between
GO and amino acids as observed in PL (cf. Fig. 5.3.2) and previous theoretical results
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[143]. The charge density changes in graphene and BN were significant (see insets in Fig.
5.3.4b-d) but much smaller compared to GO. It should be noted that the base CV loops
for GO in pure PBS solution enclose a much larger area (~ 1.75 C/m2) compared to
graphene and BN (~50-300 mC/m2) due to the presence of quinone, carboxyl, and
epoxide functional groups. The net reduction of CV loop area for GO in the presence of
amino acids is a combined effect of physi- and chemisorption. However, CV
measurements alone cannot distinguish the difference between physical and chemical
interactions. On the other hand, the micro-Raman spectrum of carbon-based ENMs is
highly sensitive to charge transfer and may be used to resolve the difference between
chemical and physical interactions. Carbon-based ENMs exhibit strong Raman features
such as the G and 2D-bands (cf. Fig. 5.3.1d), which are known to upshift (downshift)
when any acceptor (donor) species interact via hole (electron) transfer[144]. As
documented in the literature[168], the peak frequencies and shape of G- and 2D-band
depend on the Fermi energy (EF) of carbon-based ENMs. In a simplistic picture, an
upshift (downshift) in EF (or equivalently Fermi velocity) results in a downshift (upshift)
in G- and 2D-bands. Previously, Rajesh et al. [165] theoretically showed that the EF of
graphene and CNTs undergoes an overall shift (as large as 0.21 eV) upon interaction with
amino acids due to charge transfer. Indeed, their study found that the degree of shift in EF
of ENM-amino acid complexes varied as a function of the polarizability of the aromatic
moiety of the adsorbed amino acid molecules. In our studies, GO displayed a downshift
in the G-band frequency (Table 5.3.1 and Fig. 5.3.5a) for tryptophan and phenylalanine.
It should be noted that the 2D band is absent in GO due to the disruption of the so-called
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double-resonance Raman process upon the oxidation of graphene lattice[169]. The shifts
in G-band are expected due to the formation of chemical bonds, as ascertained in the
reduction in charge density from CV measurements (cf. Fig. 5.3.4). The magnitude of the
shifts in G-band of GO was highest for phenylalanine concurring with the CV data (Fig.
5.3.4d). Interestingly, tyrosine (unlike phenylalanine and tryptophan) was found to
upshift the G-band in GO although a distinct reduction in the charge density was
observed in CV measurements (Fig. 5.3.4b). Such an observation suggests that the
physisorption of tyrosine, which may preclude the participation of functional groups on
GO in electrochemical charge storage, overwhelmed the chemisorption leading to the
reduction in charge density in CV measurements.
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Figure 5.3.5: (a) Raman spectra of graphene oxide-amino acid complexes showed
significant shifts due to the formation of hydrogen bonds with amino acids. The starred
peaks arise from tyrosine due to its high Raman cross-section. (b) Raman spectra for
graphene-amino acids complexes show shifts in G- and 2D-bands (in (b) and (c)
respectively) indicating the involvement of charge transfer between amino acids and
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graphene. Solid lines in indicate fits to the experimental data. The red curves in panel (c)
are deconvoluted peaks for 2D-band in graphene.

Table 5.3.1: The positions of Raman peaks for graphene, graphene oxide, and BN-amino
acid complexes derived from Fig 5.3.5

Table 5.3.2: The positions of deconvoluted 2D-band for graphene derived from Fig.
5.3.5c.

In case of graphene, a significant downshift was observed in both G- and 2Dbands when interacting with tyrosine (Fig. 5.3.5 and Table 5.3.1). As explained earlier,
this downshifts in G- and 2D-bands of graphene-tyrosine complex could be understood in
terms of upshift in EF induced by electron-transfer from tyrosine[165]. Although a
discernible shift was observed for graphene-tyrosine complex, the widths of G- and 2D-
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band did not change significantly. The presence of chemical interactions between
graphene and tyrosine (through electron transfer) suggests that the adsorption may
predominantly be mono- or bi-layered because only the molecules within the vicinity of
graphene (~0.4-1 nm) can exhibit charge transfer and bind strongly. Based on the Raman
measurements, it is plausible that the minute changes in charge density (Fig. 5.3.4b)
resulted solely from chemisorption. On the other hand, tryptophan and phenylalanine
(Fig. 5.3.5 and Table 5.3.1) resulted in a significant broadening of G- and 2D- bands
despite little or no shift (i.e., no charge transfer) in the frequency (Tables 5.3.1 and
5.3.2). It is likely that tryptophan and phenylalanine exhibit multilayer physisorption
unlike monolayer chemisorption in the case of tyrosine. In such a scenario, the
multilayers of amino acids could contribute prominently to the non-radiative decay of
excited electrons, which could, in turn, result in the observed broadening of G- and 2Dbands. Interestingly, tryptophan exhibited an increase in the charge density due to the
presence of a new peak in the CV loop (cf. Fig. 5.3.4a and inset in Fig. 5.3.4c) suggesting
that both chemisorption and physisorption are involved.
In case of BN, we did not observe appreciable changes either in CV
measurements or Raman spectra suggesting the absence of chemisorption. Such a result
is expected due to the localization of -electrons around N in BN unlike uniformly
distributed -electron cloud in graphene or chemically active functional groups in GO.
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5.3.2 Effect of surface functional groups on AgNP-apolipoprotein corona

Figure 5.3.6: Transmission electron micrographs showing as-purchased Ag NPs (a-d)
with citrate, PVP, bPEI and lipoic acid coatings respectively. The presence of biocorona
(see arrows in e-h) upon incubation with ApoA-I was assessed using OsO4 staining as
shown in (e-h). Scale bar is 100 nm.

As shown in Fig. 5.3.6, TEM images confirmed that all four types of AgNPs
(citrate, PVP, bPEI, and lipoic acid coated) are spherical in shape with a similar size ~100
nm in their dehydrated state. ApoA-I appeared to non-uniformly adsorb on to AgNPs
(Fig. 5.3.6e-h) with a strong preference for rough edges (see Fig. 5.3.6.f and h). Given
the small size of ApoA-I protein (hydrodynamic size ~ 8 nm) relative to 100 nm AgNPs,
the corona possibly consisted of multiple ApoA-I layers. In some cases, ApoA-I was
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found to envelop AgNP aggregates in the dehydrated state under TEM similar to previous
observations [170].
Although all AgNPs have the same size in their dehydrated size (as evidenced by
TEM), we found that their hydrodynamic sizes (SHD) differed from each other in the
following order: bPEI (~135 nm) > PVP (~120 nm)>lipoic acid (~108 nm)> citrate (~100
nm). This trend is expected based on the size of the surface coating molecules where
polymers (bPEI and PVP) are significantly larger than the smaller citrate and lipoic acid
groups. The difference in the surface coatings was also evident from their zeta potential
() measurements where bPEI is positively charged with a relative low  ~8.89 mV while
citrate (mV), PVP (mV), and lipoic acid (mV) exhibited larger
negative values. Based on the zeta potential measurements, negatively charged ApoA-I
((mV [170]) is expected to display strong electrostatic attraction towards bPEI
coated AgNPs and possibly experience some repulsion from other negatively charged
AgNPs.
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Figure 5.3.7: (a) The hydrodynamic size of AgNPs was found to change with increasing
ApoA-I concentrations with saturation >2 g/L for AgNP-PVP, citrate, and lipoic acid
coatings. AgNP-bPEI, however, did not show such saturation. (b) The zeta potential
measurements showed clear changes indicating the displacement of surface coatings by
ApoA-I. All surface coatings showed saturation in zeta potential changes >2 g/L
excepting AgNP-lipoic acid. Based on (a) and (b), it could be inferred that AgNP-bPEI
and AgNP-lipoic acid do not show saturation in protein adsorption even at high ApoA-I
concentrations. It should be noted that the physiological concentration of ApoA-I is 1.31.5 g/L.

We studied the evolution of SHD and of AgNPs in the presence of ApoA-I (Fig.
5.3.7a and b). In case of bPEI, decreased rapidly and changed from a positive to a
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negative value in the presence of ApoA-I. Indeed, values at higher ApoA-I
concentrations (~-24 mV) suggest that ApoA-I stabilized AgNPs better than bPEI. A
concomitant decrease in SHD of AgNP-bPEI suggested that ApoA-I has a higher affinity
for AgNP surface and ultimately replaced bPEI on AgNP surface. The surface potential
of AgNP-PVP decreased with increasing concentration of Apo-A1 similar to bPEI.
However, SHD showed a sharp increase with a rapid saturation at a relatively low
concentration of ApoA-I (<1 g/L). Unlike AgNP-bPEI and AgNP-PVP, a significant
increase in SHD for AgNP-lipoic acid was observed only at higher ApoA-I concentrations
(>2 g/L). The observed changes in both and SHD were much slower for lipoic acid and
can be rationalized in terms of relatively strong Ag-S interactions (binding energy ~217
kJ/mol [171]) between sulfur in lipoic acid and the surface of AgNPs. Interestingly,
AgNP-citrate showed relatively smaller changes in SHD and compared to other surface
coatings. Nevertheless, in all cases, the increase in SHD did not indicate the formation of
AgNP aggregates unlike in the dehydrated state. We found that the changes in SHD and
saturated above 2 g/L for all surface coatings excepting bPEI and lipoic acid. While
SHD for AgNP-lipoic acid appears saturated, its did not suggest that protein adsorption
did not saturate. When the average time between consecutive collisions (c) of ApoA-I
with AgNPs is greater than ApoA-I configurational relaxation time (R), there is
sufficient time for ApoA-I to unfold on AgNP surface and thus could form a disorganized
corona. This condition (c>R) occurs at low ApoA-I concentrations (<2 g/L) for AgNPPVP and AgNP-citrate. Indeed, disorganized protein agglomerates can be clearly
observed on AgNP-PVP surface. However, at higher c ~R, ApoA-I cannot completely
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unfold due to rapid collisions between ApoA-I and AgNPs. This results in a densely
packed corona where ApoA-I retains much of its secondary structure. Based on the
results described in Fig. 2, it may be expected that the corona layer presents directly on
the AgNP surface is densely packed > 2g/L for all cases excepting bPEI and lipoic acid,
and thus saturates further changes in SHD and . The collision frequency (fc=1/c) of
ApoA-I molecules with AgNP surface may be calculated using the Smoluchowski
equation [172]

fc=1/c =2DCdNA

(5.2.1)

where D= 120 um2 s-1 is the room-temperature diffusion coefficient of the ApoA-I [173],
d= 12.8 nm is the room-temperature hydrodynamic diameter of ApoA-I [174] and,
NA=6.023 × 1023 mol-1 is the Avogadro number, and C is the ApoA-I concentration at
which adsorption saturates. At C= 2 g/L, we find that c ~ 90 s, which is on the same
scale as protein unfolding timescales. It should be noted that the value of c derived from
the above analysis only provides an estimate for the unfolding timescales. Nevertheless, it
could be used to infer that ApoA-I molecules will collide on a timescale of few tens of s
at physiological concentrations ~1.3-1.5 g/L, leading to a rapid saturation in adsorption
[175].
It is well known that some proteins change their conformation upon binding to
nanoparticle surfaces. Previously, Cukalevski et al. studied the conformational changes
of ApoA-I on polystyrene (PS NPs) and NIPAM/BAM (N-isopropylacrylamide-co-N-
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tert-butylacrylamide) small sized nanoparticles (<60 nm) with large curvature and
different surface charges [163]. They found that plain and negatively charged PS NPs
(diameter ~23-24 nm) slightly increased the helical structure of ApoA-I in the range of 215 % whereas positively charged PS NPs (diameter ~57 nm) slightly reduced the amount
of helical structure by ~10%. A similar study by Li et al. on 30 nm negatively charged
AgNPs and ApoA-I [170] also found a reduction of helical content by ~15-20%.
Although these previous reports provide some preliminary understanding of ApoA-I
interactions with ENMs, a controlled study with AgNPs of the same size but different
surface coatings is necessary to understand the influence of surface change. In this study,
we used 100 nm AgNPs with different surface coatings to clearly distinguish the effects
of surface charges and understand the mechanisms involved in ENM-induced protein
unfolding. In our circular dichroism (CD) studies, we found that ApoA-I exhibited a
significant decrease in the helical content by >40% on all 100 nm. ApoA-I unfolding is
more pronounced in our case due to the large AgNP size compared to previous studies
[163], [170]. The CD spectra revealed that the changes in helical content were more
prominent for AgNP-bPEI and AgNP-lipoic acid compared to PVP and citrate coatings.
Indeed, the helical content of ApoA-I may be completely suppressed for these AgNPs
(Fig. 2.2.1). These changes were accompanied by a concomitant increase in -sheet and
random chain structures in the following order: AgNP-PVP<AgNP-citrate<AgNP-lipoic
acid~AgNP-bPEI.
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Figure 5.3.8: (a) Cyclic voltammetry scans showed the appearance of a peak (blue
arrows) for AgNP electrodes in ApoA-I electrolyte suggesting the presence of chargetransfer stabilizing interactions. The peak for AgNP-bPEI occurred only in the forward
scan (going from -0.4 to 0.8 V) indicating irreversible charge transfer. A valley (red
arrows), the representative of reversible charge transfer, was observed for other surface
coatings on the reverse scan (0.8 to -0.4 V). (b) The total charge enclosed by the CV
curves in (a) displayed clear increasing trends with ApoA-I concentration confirming that
the charge-transfer occurs due to interactions between ApoA-I and AgNPs.

As shown in Fig. 5.3.8, we performed cyclic voltammetry (CV) to develop a
mechanistic understanding of surface charge dependent conformational changes observed
in CD spectra (Fig. 2.2.1). Proteins interact with ENM surfaces through intramolecular
bonds, ionic bonds, and charge transfer [156], [157]. A stabilizing charge may be
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transferred between proteins and ENM surface depending upon their electronic energy
levels, and the adsorbed proteins may undergo various conformational changes during the
electron exchange process. Charge transfer processes and the relative differences between
electronic energy levels of protein and ENM surface could be ascertained through peaks
in current (i.e., charge flow) during a CV scan [58], [172].
In the CV scan of AgNPs without ApoA-I (dashed lines in Fig. 5.3.8a), we did
not observe any peaks for all four surface coatings. The addition of ApoA-I to the
electrolyte resulted in a change in voltammetric responses with the appearance of a new
peak (blue arrows in Fig. 5.3.8a), which in turn increased the current considerably. This
new peak cannot be attributed to desorption of adsorbed hydrogen (which is known to
occur ~990 mV vs. Ag/AgCl electrode [172]) as the peak appeared at appreciably low
potentials < 350 mV for all the coatings. We attribute this peak to stabilizing electron
transfer between ApoA-I and AgNP surface. The electron transfer occurs only when the
electronic energy levels of ApoA-I are in the vicinity of AgNPs energy levels. The socalled Fermi energy (EF) or the chemical potential of AgNPs (that serve as the working
electrode in our CV measurements) is decreased (/increased) when the voltage in a CV
scan is increased (/decreased). An electron transfer occurs when the energy levels of
ApoA-I match the altered EF of AgNPs at a particular voltage in the CV scan. This peak
voltage for electron transfer was found to be much lower for AgNP-bPEI and AgNPlipoic acid (~60 mV) compared to AgNP-citrate and AgNP-PVP (~300 mV) suggesting
that the surface coatings have considerable influence of electron transfer reactions
between ApoA-I and AgNPs (Fig. 5.3.8a). The surface coatings have different electronic
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nature relative to each other and may lead to charge transfer peak at different potentials.
The electrochemical charge transfer (Q) can be quantified by calculating the area
enclosed by CV curves (Fig. 4a). We found that all the AgNPs showed an increase in Q
with increasing ApoA-I concentration concurring with our hypothesis that the observed
peak arises from electron transfer between ApoA-I and AgNPs. The normalized areal
charge density (Q/cm2) at higher ApoA-I concentrations showed the following trend:
AgNP-PVP>AgNP-citrate>AgNP-lipoic acid>AgNP-bPEI. This trend appeared to match
the changes in CD spectra described earlier in Fig. 2.2.1.
An interesting feature in the CV scans was the presence of an irreversible charge
transfer peak for AgNP-bPEI. For bPEI coating, a peak was observed only when the
voltage was increasing in the CV scan indicative of irreversible charge transfer. On the
other hand, CV scans for AgNP-citrate, AgNP-PVP, and AgNP-lipoic acid exhibited an
observable valley (see red arrows in Fig. 5.3.8a) during the reverse voltage sweep
suggesting that the observed Q for these coatings does not entirely result from
irreversible charge transfer reaction. This reversible peak may possibly be attributed to
the formation of hydrogen bonds between ApoA-I and surface coatings (PVP, citrate, and
lipoic acid). Given that bPEI showed completely irreversible stabilizing charge transfer,
we expect greater conformational changes in ApoA-I. In other words, the loss of ApoA-I
secondary structure on bPEI coated AgNPs precludes reversibility of charge transfer.
Such an observation suggests concurs with the CD spectra, which showed complete loss
of helical content in bPEI coatings. It could be expected that the disruption of
stabilizing hydrophobic interactions in the interior of the protein results in an irreversible
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charge transfer and ensue in ApoA-I structural relaxation on AgNP-bPEI. On the other
hand, AgNP-PVP and AgNP-citrate facilitate hydrogen bond formation with substantial
retention of the helical content. Returning to Fig. 2.3.1, the loss in -helical content of
ApoA-I on AgNP-lipoic acid cannot be explained based on charge transfer. It is possible
that the ApoA-I molecule unfolds on AgNP-lipoic acid surface to increase its interaction
with AgNP surface in order to break strong Ag-S interactions in AgNP-lipoic acid.

Figure 5.3.9: DCF assay was used to evaluate the ability of AgNPs with (+Apo) and
without (-Apo) ApoA-I corona to generate reactive oxygen species (ROS). AgNP-bPEIApoA-I displayed a significant increase in ROS generation compared to AgNP-bPEI
while the response to AgNP-lipoic acid-ApoA-I was significantly higher than the control.
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These changes may be attributed the protein unfolding observed in AgNP-bPEI and
AgNP-lipoic acid.
We assessed the ability of AgNPs with and without ApoA-I corona to generate
intracellular ROS by RAW 264.7 macrophages after 1 h exposure using DCF
fluorescence assay. As shown in Fig. 5.3.9, we did not observe any significant changes
(relative to control) in ROS generation for pristine AgNPs without ApoA-I corona
irrespective of their surface coatings. However, we found that the addition of ApoA-I
corona changed the response of AgNP-bPEI-ApoA-I relative to AgNP-bPEI without
corona and AgNP-lipoic acid-ApoA-I relative to the control. Based on our CD and CV
results, we attribute these changes to the adsorption and unfolding of ApoA-I on AgNPbPEI and AgNP-lipoic acid. Additionally, in case of AgNP-bPEI, ApoA-I corona resulted
in an increased surface charge (accompanied by a change from positive to negative sign)
and better stability (cf. Fig. 5.3.7b) that could have also been a contributing factor to the
observed increase in ROS generation. Despite these changes in ROS generation, we did
not observe any significant differences in the cytotoxicity of AgNPs before and after
ApoA-I adsorption. Furthermore, our flow cytometry data did not show significant
changes for AgNPs upon the addition of ApoA-I corona. Based on these results, changes
in AgNP dissolution or uptake upon the addition of ApoA-I corona could be ruled out as
a possible cause for the observed differences in ROS generation.

111

5.4 Conclusions

In summary, our dynamic and electrophoretic light scattering studies showed that
ApoA-I displaces surface coatings such as citrate, PVP, and bPEI even at low
concentrations (< 2 g/L). In case of AgNP-lipoic acid, strong Ag-S interactions inhibit
ApoA-I adsorption for concentrations below 2 g/L. Circular dichroism studies showed a
significant decrease in -helical content for all surface coatings with the complete
disappearance of helices for AgNP-bPEI and AgNP-lipoic acid. The changes in
secondary structure concur with the observed charge transfer, measured using cyclic
voltammetry, between ApoA-I and AgNPs. The unfolding of ApoA-I on AgNP-lipoic
acid cannot be completely explained in terms of charge transfer. It is plausible that
ApoA-I unfolds on the surface to lower its free energy and thereby break strong Ag-S
interactions in AgNP-lipoic acid. Lastly, we found a significant increase in the ability of
ApoA-I coated AgNP-bPEI and AgNP-lipoic acid to generate reactive oxygen species,
which can be attributed to changes in surface charge and the unfolding of ApoA-I.
We have systematically carried out photoluminescence (PL), cyclic voltammetry
(CV), and Raman measurements to elucidate the nature of interactions of aromatic amino
acids with two-dimensional materials including graphene, BN, and graphene oxide (GO).
PL and CV studies revealed that GO interacts strongly with tyrosine and tryptophan via
H-bonding compared to graphene, which exhibited π−π interactions. We also found
significant charge transfer between graphene and GO complexes with aromatic amino
acids, as verified from CV measurements and Raman spectra. BN, on the other hand, did

112

not show considerable chemical interactions with aromatic amino acids due to localized
π-electron clouds. The adsorption of amino acids was found to alter the potential of
twodimensional materials to generate reactive oxygen species (ROS). We did not find
significant changes in the ROS levels for graphene, whereas GO and BN showed
significant differences, which could be explained on the basis of PL and CV
measurements. In summary, the presence of functional groups and π−π interactions play a
significant role in the adsorption of amino acids on 2D materials.
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CHAPTER SIX
ENVIRONMENTAL IMPACTS OF TWO-DIMENSIONAL MATERIALS

6.1 Introduction
The recent emergence of two-dimensional engineered nanomaterials (2D-ENM)
enabled the advancement of electronics, sensors, coatings, water treatment membranes,
and energy storage and conversion devices.[176]–[178] The unique properties of 2DENMs provide advantages for many environmental applications such as i)
sorbents/photocatalytic materials for environmental remediation including radioactive
waste removal [179], [180], ii) next-generation water treatment membranes[181], and iii)
sensors for real-time contaminant monitoring.[182] As the production and technological
applications of 2D-ENMs continue to grow in the coming years[183], it is imperative to
study their environmental interactions for understanding 2D-ENM fate, transport, and
toxicity in order to mitigate any potential risks.[184] It is likely that the high surface area
of

2D-ENMs

amplifies

their

environmental

interactions

relative

to

other

nanomaterials.[185] 2D-ENMs discharged into the environment, either from the
production facilities or at the end of the product lifecycle, will inevitably bind with
natural organic matter (NOM) in water, sediments, and soils. Drawing from our previous
studies on the effects of protein binding to ENMs or “protein corona” formation in
mammalian cells, we hypothesize that the interactions of 2D-ENMs with NOM modify
their surface through the formation of a biocorona and thereby influence their stability
and interactions with algae.[164], [186]–[188]
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The objective of this study is to investigate the interactions of aquatic NOM
(Suwanee River and Nordic reservoir NOMs labeled as SRNOM and NRNOM) with two
important 2D-ENMs viz., few-layer graphene and BN. Graphene and BN are structural
homologues with differences in -electron cloud distribution (delocalized in graphene
and localized on N in BN), which present good experimental platforms for studying 2DENM-NOM interactions.[189] In this study, optical absorption and photoluminescence
(PL) spectroscopy in addition to electrochemical measurements were used to elucidate
the nature of interactions between NOM and 2D-ENMs. Graphene and BN were found to
exhibit a higher affinity for SRNOM, which had more aromatic content than
NRNOM. The delocalized  -electron cloud in graphene facilitated chemisorption of both
SRNOM and NRNOM, as evidenced by the electrochemical charge transfer between
graphene and NOMs. On the other hand, BN exhibited little or no charge transfer with
both SRNOM and NRNOM. Importantly, the formation of NOM biocorona significantly
impacted the interaction of 2D-ENMs with algal cells. Particularly, the increased surface
charge of BN-SRNOM complexes was found to mitigate the adverse effects of BN on
algal photosynthesis. These results suggest that it is critical to include the effects of
biocorona for assessing the environmental impact of 2D-ENMs.

6.2 Materials and methods

Graphene and BN platelets were synthesized using chemical exfoliation technique
described in Ref. [190]. Briefly, graphene/BN platelets were synthesized using the
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chemical exfoliation technique. Bulk graphite (∼1 g) or BN was suspended in 100 mL of
N-methyl-2-pyrrolidinone (NMP) and sonicated using 1/8” tip sonicator (Branson 250) at
100 W for 2 h. After sonication, the suspension was centrifuged at 3000 rpm for 30 mins,
and the supernatant was filtered through 0.45 μm nylon filter and resuspended in 100 mL
of fresh NMP. This fresh solution was sonicated again for 6 h, and the centrifuged at
1500 rpm for 1 hr. The supernatant was then vacuum filtered using a 0.45 μm nylon filter.
The filtered powder was washed several times using deionized water to remove residual
NMP and air-dried to obtain exfoliated graphene/BN samples
Suwannee River and Nordic reservoir NOM (SRNOM and NRNOM) were
purchased from International Humic Substance Society (IHSS #1R101N and 1R108N)
while humic acid was procured from Sigma-Aldrich. Graphene and BN platelets were
incubated in SRNOM and NRNOM for 12 hrs at different concentrations to obtain the
adsorption isotherms. After incubation, samples were centrifuged at 13,000 rpm and the
supernatant was removed. Subsequently, these samples were washed thrice with DI water
to remove any loosely bound NOM. Zeta potential was measured using a Malvern
Zetasizer. At least ten measurements were performed for each sample to obtain an
average zeta potential. Transmission electron microscopy images were obtained using
Hitachi H7600 and H9500. The absorbance at 254 nm was monitored using a Perkin
Elmer Lambda 950 UV/Vis spectrometer to characterize the amount of adsorbed NOM.
Fluorescence spectra were obtained using a Horiba-Jobin Yvon Nanolog coupled to a
liquid N2 cooled CCD detector. At least 3 repeats were performed to obtain the average
absorbance/fluorescence. A standard curve was created using NOM stock solutions to
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obtain the relationship between absorbance at 254 nm and the NOM concentration.
Charge transfer was studied using cyclic voltammetry in a three-electrode geometry
(working electrode: 2D-ENMs, counter electrode-Pt mesh, Ag/AgCl reference, NOM as
the electrolyte) with a Gamry reference 3000 electrochemical system.
Chlamydomonas freshwater algae were purchased from Carolina Biosupply
(#152030) and cultured in soli-water medium (#153760) at room temperature under 300
foot-candles illumination for 7 days prior to the experiments. The algal photosynthesis
was studied by monitoring CO2 depletion using a bicarbonate indicator solution (0.2 g of
thymol blue, 0.1 g of cresol red, in 0.01 M NaHCO3).[191] For CO2 depletion studies, the
indicator solution was mixed with algae and 2D-ENMs (with and without NOMs; 15, 30,
and 80 g/ml) solution in an airtight tube. The algal photosynthesis depletes CO2 in the
indicator solution (coming from NaHCO3) and thereby alters the pH, which can be
monitored by optical absorbance at 574 nm. All the studies were repeated at least with
three different sets of algae to obtain statistically meaningful results. The bright-field
images of algae with 2D ENMs were obtained using the Axio Imager A1, Zeiss.
6.3 Results and discussion

As shown in Fig. 6.3.1, graphene (~10-15 layers) and BN (~20-25 layers)
exhibited sheet-like structure, which is a characteristic of 2D-ENMs. Both pristine
graphene and BN were found to have a negative surface charge in DI water, as indicated
by their zeta potentials -45 and -26 mV, respectively (see Table 1). Upon NOM
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adsorption, the zeta potential of graphene and BN significantly increased suggesting
better stability due to electrostatic repulsion. The effect of NOMs in improving the
suspension stability was more pronounced for BN with a markedly higher surface charge
on BN-SRNOM and BN-NRNOM.

Figure 6.3.1: High-resolution transmission electron microscope images of pristine
graphene and BN shows a layered structure with ~10-15 layers for graphene and 20-15
layers for BN. The insets show graphene and BN flakes at lower magnification with
lateral sheet dimensions >1 m.
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Zeta potential (mV)
SRNOM

-18.07

NRNOM

-11.14

Graphene
Graphene + SRNOM

-44.96
(
-71.42

Graphene + NRNOM

-54.57

BN

-26.38

BN + SRNOM

-69.77

BN + NRNOM

-50.86

Table 6.3.1: Zeta potential values to understand the stability of NOM with 2D materials
in the aquatic environment. The result shows graphene and BN stabilize the NOM
suspended water.
The adsorption of SRNOM and NRNOM was found to follow a Freundlich
isotherm (Fig. 6.3.2) given by
(6.1)

where qe is the amount of NOM adsorbed on 2D-ENMs, Ce is the total concentration of
NOM in which Kf (and 1/n) for SRNOM was higher (/lower) than NRNOM (Table 2)
suggesting that both graphene and BN showed a greater affinity for SRNOM. This
improved affinity was also reflected in the higher zeta potentials for SRNOM-coated
graphene and BN (cf. Table 1). Such a result may be partly understood in terms of better
 interactions[192]–[194] arising from higher aromatic content in SRNOM. NOM is a
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heterogeneous mixture of a variety of organic compounds, consisting of aromatic,
aliphatic, phenolic, and quinolinic functional groups with varying molecular sizes and
properties.[195], [196] The aromatic content in NOM exhibits characteristic fluorescence
spectra when excited by UV-light. This fluorescence intensity of NOM was previously
used for qualitatively comparing the aromatic content between different types of
NOM.[197], [198] Strong fluorescence emission ~450-500 nm was observed for both
SRNOM and NRNOM when excited at 330 nm. However, the fluorescence emission
from NRNOM was weaker compared to SRNOM, which could be attributed to its lower
aromatic content. To further validate the hypothesis that SRNOM exhibits greater affinity
due to higher aromatic content, the adsorption isotherms of 2D-ENMs with humic acid or
HA, which has a lower aromatic content (and hence lower fluorescence intensity), were
measured. As expected, both graphene and BN exhibited significantly lower adsorption
of HA with much lower Kf values confirming our hypothesis (Fig. 6.3.2).

Figure 6.3.2: Adsorption isotherms of NOM on (a) graphene and (b) BN showed that
Suwanee River NOM (SRNOM) exhibited higher affinity relative to Nordic reservoir
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NOM (NRNOM) and humic acid (HA) that have lower aromatic content. The solid lines
are fits obtained using Freundlich equation. Fitting parameters are listed in Table 6.3.2.

Gr -SRNOM
Gr – NRNOM
Gr – Humic acid
BN – SRNOM
BN – NRNOM

Kf
0.72
0.41
0.51
0.22
0.13

1/n
0.95
1.63
0.39
1.8
2.24

BN – Humic acid

0.07

1.88

Table 6.3.2: Freundlich adsorption model parameters for graphene, BN with NOMs.
NOM adsorption on many porous materials is strongly influenced by the physical
structure of the adsorbent.[199] Although a porous adsorbent (e.g., activated carbon) may
have a high affinity for the NOM, its adsorption capacity could be limited by the
accessible surface area because larger molecules in NOM are often blocked by
micropores and some mesopores[200]–[202]. In such cases, the relationship between Kf
and 1/n is not linear. In case of graphene and BN, however, it was observed that Kf and
1/n are inversely proportional (see Table 6.3.2) suggesting that NOM adsorption on 2DENMs is only weakly influenced by their physical structure.
While  interactions play an important role in the adsorption of NOMs on
graphene and BN, an interfacial charge transfer between adsorbed NOM and 2D-ENMs
can stabilize the 2D-ENM-NOM complexes by decreasing their total energy through
charge redistribution. Thus, in addition to the adsorption isotherms, cyclic voltammetry
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(CV) was performed to study the charge transfer interactions between 2D-ENMs and
NOM. As described in the experimental section, 2D-ENMs were used as the working
electrode while NOM dissolved in DI water was used as the electrolyte for CV
measurements. A typical CV scan is performed by cycling the applied voltage on the
working electrode (2D-ENMs in our case) between two voltage values while
concomitantly measuring the current. The voltage values were chosen to be -0.2 and 0.8
V to avoid the electrolysis of water (see Fig. 6.3.3). The applied voltage on the working
electrode upshifts (/downshifts) it's electronic energy levels for negative (/positive)
voltages. A charge transfer or exchange occurs, between the working electrode and the
electrolyte, when some electronic energy levels of the working electrode (for example,
lowest energy level in the conduction band or the highest energy level in the valence
band) matches either the highest occupied molecular orbital (HOMO) or lowest
unoccupied molecular orbital (LUMO) energy states of the electrolyte. In a CV scan, a
peak in the current occurs when there is a charge transfer between the working electrode
and the analyte (NOM in this case) dissolved in the electrolyte. As shown in Fig. 6.3.3a
and b, clear irreversible peaks were observed for graphene with both SRNOM and
NRNOM indicating the presence of charge transfer reactions. On the other hand, no
prominent peaks were found for BN. Such a result is expected the localization of electrons on N atoms in BN precludes charge transfer reactions unlike delocalized electron cloud in graphene. Similar behavior of graphene and BN was also observed in
their interactions with aromatic amino acids. [203]
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Figure 6.3.3: Cyclic voltammograms of graphene and BN in (a) Suwanee River NOM
(SRNOM) and (b) Nordic reservoir NOM (NRNOM): A clear irreversible charge transfer
peak (indicated by solid arrows) was observed for graphene while BN did not exhibit any
peaks. The dashed arrows indicate the electrolysis of water in the electrolyte at higher
voltages. A slow scan rate (~ 5 mV/s) was used in order to exclude any electrolyte
diffusion effects.
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Figure 6.3.4: Charge transfer isotherms for Suwannee Rive & Nordic reservoir NOM
(SRNOM and NRNOM) on 2D-ENMs show that NOM adsorption on graphene involves
chemisorption, unlike BN. The observed differences between graphene and BN could be
attributed to the delocalized -electron cloud in graphene that facilitates charge transfer
with aromatic content in NOM.

For a given NOM concentration, the electrochemical charge transfer can be
quantified using the difference in the area enclosed by the CV curve for electrolytes with
and without NOM. As shown in Fig. 6.3.4, CV curves were measured at different NOM
concentrations to obtain charge-transfer isotherms. The charge-transfer isotherms for all
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2D-ENMs and NOM combinations showed clear increasing trends as a function of
concentration. In case of graphene, SRNOM showed higher charge transfer compared to
NRNOM concurring with the results described in Fig. 6.3.2. It is plausible that higher
aromatic content in SRNOM promotes charge transfer reactions with graphene, in
addition to  interactions, to facilitate chemisorption. The isotherms for BN showed no
significant increase in charge transfer with increasing NOM concentration possibly due to
insulating nature of BN and weaker  interactions resulting from the localization of electron cloud on N-atoms.
Considering that living organisms in the environment may be exposed to 2DENMs through industrial and research waste, the effects of 2D-ENM-NOM biocorona on
algal photosynthesis were evaluated[191], [204]. Algae are an important component of
our environment and ecosystem and contribute ~40% of global biomass. In this regard, it
is imperative to understand the effects of 2D-ENMs entrained in NOM biocorona on
algal toxicity. Single-celled algae, Chlamydomonas sp., were used as the model system to
examine the effects of NOM biocorona on CO2 depletion (Fig. 6.3.5 and 6.3.6).
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Figure 6.3.5: (a-c) Algae incubated in graphene, graphene with Suwannee and graphene
with Nordic. (d-f) Algae incubated in BN, BN with Suwannee and BN with Nordic. The
scale bar is 100 µm.
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Figure 6.3.6: CO2 depletion rate measured at 574 nm (as absorbance peak occurs for
bicarbonate indicator) for (a) graphene and (b) BN samples at different intervals of time
upon incubation with algae.

As shown in Fig. 6.3.5, pristine and NOM coated graphene were found to
aggregate into ~10-100 m clusters in the algal medium. Such large aggregates were not
observed in case of BN. The algal cells retained their spherical shape when exposed to
pristine and NOM coated graphene indicating minimal interactions between graphene and
algae. On the other hand, algal cells appeared oblate with ruptured cell walls when
exposed to pristine and NOM coated BN. The observed rupturing may be attributed to
adsorption and uptake of BN through nitrate/nitrite transporters proteins involved in
nitrate assimilation on the surface of Chlamydomonas[205]. Such algal cell rupture is
expected to strongly impact their photosynthetic activity. At low concentrations (15 and
30 g/ml), no significant differences were observed for the rate of CO2 depletion for both
graphene and BN (pristine and NOM coated). The rate of CO2 depletion at a higher
concentration 80 g/ml is shown in Fig. 6.3.6. The rate of CO2 depletion did not show
any significant difference for both pristine and NOM coated graphene concurring with
bright-field microscopy images. However, BN and BN-NRNOM were found to
significantly decrease the CO2 depletion rate. This could be rationalized in terms of the
light blocking from the photosynthesis centers due to adsorption of the BN and BNNRNOM on algae. Interestingly, BN-SRNOM showed a CO2 depletion rate similar to the
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control plausibly because of the inhibition of its interaction with nitrate/nitrite
transporters proteins due to higher zeta potential relative to BN and BN-NRNOM.

6.4 Conclusions

In summary, the adsorption of NOM was found to increase the surface charge of
graphene and BN, which led to better suspension stability. Suwanee River NOM showed
higher affinity for graphene and BN due to a higher aromatic content compared to Nordic
NOM and humic acid. A clear signature for charge transfer between NOMs and graphene
was observed in cyclic voltammetry suggesting that chemisorption of NOMs. The cell
walls of algae were found to be ruptured upon exposure to pristine and NOM coated BN,
which could be possibly attributed to interactions between BN and algal surface
transporter proteins involved in nitrate assimilation. While pristine and NOM coated
graphene did not result in algal cell rupture or change CO2 depletion rate, BN and BNNRNOM were found to significantly decrease the CO2 depletion.
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CHAPTER SEVEN
SUMMARY AND FUTURE WORK
Vast commercial products integrated with nanomaterials have posed pressing
concerns and need for thorough assessment of nanoparticle toxicity. Eventually, these
produced goods enter aquatic environment posing threat to aquatic organisms. In this
emerging field of nanotoxicity, we have presented a study of biocorona variation with
defects, surface functional groups of nanomaterials and also in the altered physiological
state. Future direction will further address the ability of carboxylated MWCNTs to
deliver the antigen or allergen in animal studies, and further investigate the toxicity using
various methods, as well as the possibility of different surface functionalization to alter
the immune response in vivo. In addition, future studies should examine efficient methods
to modify the frequency of defect sites on MWCNTs to improve their capability to bind
antigen and optimize MWCNT-based drug/antigen delivery systems.
There still lies action mechanisms that govern nanomaterial toxicity yet to be fully
uncovered. Some overlooked factors like protein gradient, temperature and its effects on
the composition of biocorona need to be thoroughly assessed. It will be of great interest
to understand the implications of nanoparticle-induced cellular toxicity, genotoxicity,
bioaccumulation etc. Although studies of environmental impacts of ENMs has grown
exponentially, we still lack a complete understanding of its fate, transport, and toxicity in
the aquatic environment. Further research studies will enable us to build a predictive
model for nanomaterial toxicological effects which guides in the selection and potential
safe applications in near future.
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APPENDIX
Glossary of acronyms used in the dissertation
1. ENMs: Engineered Nanomaterials
2. BC: Biocorona
3. MD: Molecular Dynamics
4. CD: Circular Dichroism
5. TEM: Transmission Electron Microscopy
6. SEM: Scanning Electron Microscopy
7. 2D: Two-dimensional
8. SWCNTs: Single-Walled Carbon Nanotubes
9. MWCNTs: Multi-Walled Carbon Nanotubes
10. AFM: Atomic Force Microscopy
11. RAEC: Rat Aortic Endothelial Cells
12. ICP-MS: Inductively Coupled Plasma-Mass Spectrometry
13. NOM: Natural Organic Matter
14. Gr: Graphene
15. NPs: Nanoparticles
16. DOS: Density of States
17. FTIR: Fourier Transform Infrared Spectroscopy
18. BSA: Bovine Serum Albumin
19. PVP: Polyvinylpyrrolidone
20. bPEI: branched Polyethylenimine
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